Application of FUNDC1 inhibitor in preparation of medicine for preventing and treating skin light injury
By developing FUNDC1 inhibitors, genetic engineering technology is used to reduce FUNDC1 expression, the problem of skin light damage caused by ultraviolet radiation is solved, and cell damage and apoptosis is significantly reduced, providing an effective method to prevent and treat skin light damage.
Patent Information
- Application Number
- CN202411099059.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-02-21
- Filing Date
- 2024-08-12
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-08-12
AI Technical Summary
The prior art is difficult to effectively solve skin light damage caused by ultraviolet radiation, especially the role of FUNDC1 in this process has not been fully studied and utilized.
FUNDC1 inhibitors were developed, including small-molecular compounds, polymers, peptides, proteins and nucleic acid substances, to silen or knock out the FUNDC1 gene through genetic engineering to reduce the expression of FUNDC1, thereby inhibiting or reducing ROS levels and reducing cell apoptosis. Death and necrosis, alleviate nuclear damage, regulate mitochondrial distribution and membrane polarization, and thus alleviate or prevent skin light damage.
By reducing FUNDC1 expression, skin light damage caused by ultraviolet radiation is significantly reduced, cell survival rate is improved, mitochondrial damage and apoptosis are reduced, skin cells are protected, and potential targets are provided for preventing and treating skin light damage.
Smart Images

Figure CN119074924A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to application of a FUNDC1 inhibitor in the preparation of a drug for preventing and treating skin photodamage. Background Art
[0002] Mitochondria generate most of the energy of cells through oxidative phosphorylation and ETC, which exists in the form of ATP and provides energy for cell life activities. During oxygen metabolism, mitochondria produce a natural byproduct mtROS, which leads to mtDNA mutation. Ultraviolet radiation (UVR, 295-400nm) reaching the earth's surface includes UVA (long-wave dark spot effect ultraviolet, 320-400nm) and UVB (medium-wave ultraviolet, 280-320nm). Although UVB accounts for only 5% of the ultraviolet (UV) reaching the ground, its energy is higher than that of UVA, and its side effects on the skin are more significant. UVB can penetrate the epidermis, while UVA mainly penetrates the dermis. UV can cause acute or chronic photodamage to human skin, and acute photodamage is mainly caused by UVB. Ultraviolet rays can damage mitochondria in skin cells (including keratinocytes, epidermal stem cells, melanocytes, fibroblasts, etc.). UV can induce oxidative stress and mitochondrial DNA (mtDNA) damage, including mitochondrial ROS (mtROS) production and mtDNA mutation, which leads to mitochondrial depolarization, mitochondrial dysfunction, and skin photodamage. Based on the above mechanism, mitochondrial abnormalities are involved in UV-induced skin damage.
[0003] FUNDC1 is a key receptor that regulates mitochondrial autophagy. It is composed of 155 amino acids and is a highly conserved transmembrane protein in most mammals (including humans). FUNDC1 can interact with LC3 to mediate mitochondrial autophagy. Under normal circumstances, FUNDC1 can stably exist in the outer membrane of mitochondria without mediating the occurrence of mitochondrial autophagy. That is, under normal conditions, FUNDC1 is phosphorylated by tyrosine kinase, at which time the affinity with LC3 is weak, and autophagy is inhibited; under ischemic and hypoxic conditions, tyrosine kinase is inactivated, the affinity of FUNDC1 with LC3 is significantly increased, and FUNDC1 can be activated by serine / threonine protein phosphatase through dephosphorylation, thereby inducing the occurrence of mitochondrial autophagy.
[0004] Mitochondrial autophagy can remove damaged and unnecessary mitochondria in cells and is involved in the energy balance of cells under different pathological conditions. During photodamage, PINK1-Parkin-mediated mitophagy needs to be activated under certain conditions, and BNIP3-mediated mitophagy is sometimes not sufficient to protect cells from photodamage. Although studies have shown that light radiation can induce autophagy in some mitochondria, there are no reports on how FUNDC1-mediated mitophagy behaves in ultraviolet radiation (UVR) photodamage. Studying the role of FUNDC1 in UVR-induced photodamage is of great significance for alleviating skin problems in the future.
[0005] In addition, on the one hand, there are differences in understanding among those skilled in the art; on the other hand, the applicant studied a large number of documents and patents when making the present invention, but due to space limitations, not all details and contents are listed in detail. However, this does not mean that the present invention does not have the characteristics of these prior arts. On the contrary, the present invention already has all the characteristics of the prior art, and the applicant reserves the right to add relevant prior art to the background technology. Summary of the invention
[0006] In view of the deficiencies of the prior art, the first aspect of the present invention provides the use of FUNDC1 inhibitors in the preparation of drugs for preventing and treating skin photodamage. FUNDC1 inhibitors include small molecule compounds, high molecular polymers, polypeptides, proteins, nucleic acid substances or viruses that can regulate the expression of FUNDC1 in the subject. Nucleic acid substances also include related substances related to FUNDC1 that are silenced, knocked out or partially knocked out based on genetic engineering. FUNDC1 inhibitors alleviate, reduce or prevent skin photodamage by inhibiting or reducing the expression of FUNDC1.
[0007] According to a preferred embodiment, the FUNDC1 inhibitor reduces the level of intracellular ROS by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0008] According to a preferred embodiment, the FUNDC1 inhibitor reduces cell apoptosis and necrosis by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0009] According to a preferred embodiment, the FUNDC1 inhibitor reduces nuclear damage by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0010] According to a preferred embodiment, the FUNDC1 inhibitor reduces the expression level of γH2Ax reflecting nuclear damage by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0011] According to a preferred embodiment, the FUNDC1 inhibitor reduces mitochondrial damage by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0012] According to a preferred embodiment, the FUNDC1 inhibitor regulates the distribution of mitochondria by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0013] According to a preferred embodiment, the FUNDC1 inhibitor promotes uniform distribution of mitochondria by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0014] According to a preferred embodiment, the FUNDC1 inhibitor regulates the polarization of mitochondrial membrane by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0015] According to a preferred embodiment, the FUNDC1 inhibitor promotes mitochondrial membrane polarization by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0016] According to a preferred embodiment, the FUNDC1 inhibitor regulates mitochondrial membrane potential by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0017] According to a preferred embodiment, the FUNDC1 inhibitor promotes the increase of mitochondrial membrane potential by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0018] According to a preferred embodiment, the FUNDC1 inhibitor promotes the expression of mitochondrial protein COX4 by inhibiting or reducing the expression of FUNDC1, thereby alleviating, reducing or preventing skin photodamage.
[0019] According to a preferred embodiment, the FUNDC1 inhibitor inhibits or reduces the expression of FUNDC1 to supplement PINK1-Parkin-mediated mitochondrial autophagy, thereby protecting mitochondria from apoptosis.
[0020] According to a preferred embodiment, the FUNDC1 inhibitor upregulates the expression of the anti-apoptotic protein Bcl2 by inhibiting or reducing the expression of FUNDC1, thereby protecting mitochondria from apoptosis.
[0021] According to a preferred embodiment, the FUNDC1 inhibitor downregulates the expression of the pro-apoptotic protein Bax by inhibiting or reducing the expression of FUNDC1, thereby protecting mitochondria from apoptosis.
[0022] According to a preferred embodiment, the FUNDC1 inhibitor protects mitochondria from apoptosis by inhibiting or reducing the expression of FUNDC1 to upregulate the expression of the anti-apoptotic protein Bcl2 and downregulate the expression of the pro-apoptotic protein Bax.
[0023] According to a preferred embodiment, the light damage is damage caused by ultraviolet radiation.
[0024] According to a preferred embodiment, the photodamage is damage caused by ultraviolet B (UVB).
[0025] According to a preferred embodiment, the silencing in the genetic engineering manner is to silence the FUNDC1 gene using shRNA.
[0026] According to a preferred embodiment, the sequence of shRNA is shown in one of SEQ ID NO: 1 to SEQ ID NO: 3.
[0027] The second aspect of the present invention provides a shRNA sequence that specifically inhibits or reduces the expression of FUNDC1, and the sequence thereof is shown in one of SEQ ID NO: 1 to SEQ ID NO: 3.
[0028] The third aspect of the present invention provides a vector, which includes the shRNA sequence provided by the second aspect of the present invention.
[0029] The fourth aspect of the present invention provides use of the shRNA sequence provided in the second aspect of the present invention or the vector provided in the third aspect of the present invention in preparing a FUNDC1 gene-deficient cell line.
[0030] The fifth aspect of the present invention provides a kit for knocking down the FUNDC1 gene, which comprises the shRNA sequence provided by the second aspect of the present invention or the vector provided by the third aspect of the present invention.
[0031] In a sixth aspect, the present invention provides an sgRNA sequence that specifically inhibits or reduces the expression of FUNDC1, and its sequence is shown in one of SEQ ID NO: 14 to SEQ ID NO: 16.
[0032] The seventh aspect of the present invention provides a vector comprising the sgRNA sequence provided by the sixth aspect of the present invention.
[0033] The eighth aspect of the present invention provides a kit for knocking down the FUNDC1 gene, which comprises the sgRNA sequence provided in the sixth aspect or the vector provided in the seventh aspect of the present invention.
[0034] A ninth aspect of the present invention provides a pharmaceutical composition for preventing and treating photodamage of the skin, the pharmaceutical composition comprising FUNDC1 and a pharmaceutically acceptable carrier or excipient, wherein the FUNDC1 inhibitor comprises a small molecule compound, a high molecular weight polymer, a polypeptide, a protein, a nucleic acid substance or a virus capable of regulating the expression of FUNDC1 in a subject, wherein the nucleic acid substance also comprises a substance related to FUNDC1 that is silenced, knocked out or partially knocked out by genetic engineering.
[0035] According to a preferred embodiment, the silencing in the genetic engineering manner is to silence the FUNDC1 gene using shRNA.
[0036] According to a preferred embodiment, the sequence of shRNA is shown in one of SEQ ID NO: 1 to SEQ ID NO: 3.
[0037] According to a preferred embodiment, the silencing in the genetic engineering method is to silence the FUNDC1 gene using sgRNA.
[0038] According to a preferred embodiment, the sequence of sgRNA is shown in one of SEQ ID NO: 14 to SEQ ID NO: 6.
[0039] The tenth aspect of the present invention provides a method for preparing a drug for preventing and treating photodamage of the skin, the method comprising: providing a FUNDC1 inhibitor; mixing the FUNDC1 inhibitor with a pharmaceutically acceptable carrier or excipient; preparing the mixture into a drug form, wherein the FUNDC1 inhibitor comprises a small molecule compound, a high molecular weight polymer, a polypeptide, a protein, a nucleic acid substance or a virus capable of regulating the expression of FUNDC1 in a subject, wherein the nucleic acid substance also comprises a substance related to FUNDC1 that is silenced, knocked out or partially knocked out by genetic engineering.
[0040] According to a preferred embodiment, the silencing in the genetic engineering manner is to silence the FUNDC1 gene using shRNA.
[0041] According to a preferred embodiment, the sequence of shRNA is shown in one of SEQ ID NO: 1 to SEQ ID NO: 3.
[0042] In an eleventh aspect, the present invention provides an application of FUNDC1 as a target in screening drugs for preventing and treating photodamage of the skin.
[0043] The twelfth aspect of the present invention provides a method for treating photodamage to a patient's skin. The method comprises applying an effective amount of a FUNDC1 inhibitor to the patient. The FUNDC1 inhibitor comprises a small molecule compound, a high molecular weight polymer, a polypeptide, a protein, a nucleic acid substance or a virus capable of regulating the expression of FUNDC1 in the subject's body, wherein the nucleic acid substance also comprises a related substance related to FUNDC1 that is silenced, knocked out or partially knocked out by genetic engineering.
[0044] FUNDC1 (FUN14 Domain Containing 1) is a protein associated with mitochondrial autophagy. Currently, for the specific inhibition of FUNDC1, the existing technology provides some methods and compounds used to inhibit or regulate the activity of FUNDC1, such as: small interfering RNA (siRNA) or short hairpin RNA (shRNA): These are gene silencing technologies that can be used to specifically reduce the expression of FUNDC1. FUNDC1 phosphorylation regulators: ULK1 inhibitors: such as SBI-0206965, can indirectly affect the activity of FUNDC1 because ULK1 is involved in the phosphorylation of FUNDC1. PGAM5 inhibitors: PGAM5 is a dephosphorylase of FUNDC1, and inhibiting PGAM5 may affect the activity of FUNDC1. Mitochondrial autophagy inhibitors: Although not directly targeting FUNDC1, they can affect the FUNDC1-mediated mitophagy process: Mdivi-1: mitochondrial fission inhibitor, 3-methyladenine (3-MA): autophagy inhibitor. Antioxidants: Some antioxidants may indirectly affect the activity of FUNDC1 by regulating oxidative stress, such as N-acetylcysteine (NAC). Specific peptide inhibitors also include small molecule compounds.
[0045] Beneficial effects: The present invention uses C57BL / 6 mice to establish a skin photodamage model. Since UVB mainly penetrates the epidermis of the skin, a cell photodamage model is established after UVB is irradiated to HaCaT cells. Gross photos show clinical characteristics of photodamage such as skin erythema, scaling and scabs, and obvious capillary dilation can be observed under polarized light of a dermatoscope. Histological examination (HE sections) showed that the mouse epidermis began to thicken 24 hours after UVB irradiation, with obvious scabs at 72 hours and a large number of inflammatory cells infiltrating the dermis, thus confirming that the mouse skin photodamage model was successfully established. CCK8 was used to evaluate the cell survival rate after UVB irradiation. At 30mJ / cm 2 At a UVB dose of 30 mJ / cm 2After irradiation, an increase in intracellular ROS, apoptosis and necrosis, and an increase in the expression level of γH2Ax were observed, further indicating that this study successfully established a UVB-induced photodamage model of HaCaT cells.
[0046] Regarding the mechanism of mitochondria in UVB-induced skin photodamage, most of them involve mitochondrial function and its related signaling pathways. In order to further explore the mechanism of mitochondria in UVB-induced photodamage, the present invention used the GEO (GSE138800) database to analyze the effect of different UVB doses (20 mJ / cm 2 and 40mJ / cm 2 The differentially expressed genes before and after irradiation were intersected with the genes related to mitochondria in the Amigo 2 database, and these genes were enriched by KEGG, indicating that mitophagy plays an important role in UVB-induced photodamage. Furthermore, the second part of the present invention explores the role of mitophagy and mitochondrial apoptosis in UVB-induced skin photodamage.
[0047] In mammals, mitophagy includes PINK1 / Parkin-dependent ubiquitin-mediated mitophagy and BNIP3 and FUNDC1-dependent receptor-mediated mitophagy. The present invention detected the expression of mitophagy-related molecules after UVB irradiation of the back skin of mice by Western blot, and found that FUNDC1 decreased 24h and 72h after UVB irradiation, while BNIP3, PINK1 and Parkin did not change. The above results indicate that FUNDC1 receptor-mediated mitophagy plays a key role in UVB-induced light damage, while ubiquitin-mediated (PINK1 / Parkin) mitophagy is not directly activated after UVB irradiation. Similarly, after exposure to 30mJ / cm 2 In HaCaT cells exposed to UVB, FUNDC1 levels decreased, while BNIP3 expression increased, indicating that changes in receptor-mediated mitochondrial autophagy occurred after UVB irradiation. In contrast, PINK1 and Parkin did not change before and after UVB exposure, which is consistent with the results of mice. In addition, the present invention also verified the expression of FUNDC1 in human specimens and found that FUNDC1 expression was reduced in sun-exposed skin, showing consistent downregulation in both mice and cells.
[0048] It has been demonstrated that FUNDC1-mediated mitochondrial autophagy is inhibited in UVB-irradiated mouse skin and HaCaT cells. Therefore, the present invention promotes mitochondrial autophagy by overexpressing FUNDC1, thereby enhancing the ability to remove damaged mitochondria and inhibiting mitochondrial apoptosis, thereby achieving the purpose of alleviating or preventing light damage. Unexpectedly, FUNDC1 overexpression exacerbates UVB-induced mitochondrial damage and light damage. After UVB irradiation, FUNDC1 overexpression causes cell survival rate to drop to 30%, accompanied by increased levels of ROS, apoptosis and γH2Ax; the aggravation of mitochondrial damage includes more significant distribution of mitochondria along the long axis of the nucleus along the two poles, further increase in mtROS and further decrease in mitochondrial membrane potential. FUNDC1 overexpression does not protect mitochondrial apoptosis-mediated light damage by promoting the removal of damaged mitochondria. On the contrary, the complete disappearance of mitochondrial protein COX4 suggests that after FUNDC1 overexpression, UVB irradiation of HaCaT cells may cause healthy and damaged mitochondria to be removed indiscriminately.
[0049] Given that FUNDC1 overexpression exacerbates UVB-induced photodamage, the present invention explores whether knocking down FUNDC1 can protect HaCaT cells from UVB-induced photodamage. After FUNDC1 knockdown, cell survival rate increased to 80%. Compared with the UVB group, ROS levels, apoptosis and γH2Ax expression were reduced. After UVB irradiation, FUNDC1 knockdown also alleviated mitochondrial damage, as manifested by uniform distribution of mitochondria along the nucleus, repolarization of mitochondrial membrane potential and reduced mtROS accumulation. In terms of mechanism research, the results of the present invention show that FUNDC1 knockdown alleviates mitochondrial damage and photodamage by compensating for PINK1 / Parkin-mediated mitophagy. Therefore, the present invention proposes that intervening in FUNDC1-mediated mitophagy can protect UVB-induced mitochondrial damage and photodamage by regulating the mitochondrial apoptosis pathway, providing a potential target for alleviating skin photodamage in the future. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] Figure 1 The present invention provides a general photograph before and after UVB irradiation and a photograph under a dermatoscope under non-polarized light and polarized light;
[0051] Figure 2 It is the HE staining result provided by the present invention;
[0052] Figure 3 The effects of different doses of UVB provided by the present invention on the survival rate of HaCaT cells;
[0053] Figure 4 It is the effect of UVB provided by the present invention on the ROS level of HaCaT cells;
[0054] Figure 5 is the level of cell apoptosis and necrosis after UVB irradiation provided by the present invention;
[0055] Figure 6 is the degree of cell nucleus damage after UVB irradiation provided by the present invention;
[0056] Figure 7 The detection results of COX4 levels in the back of UVB-irradiated mice and HaCaT cells provided by the present invention;
[0057] Figure 8 It is the statistical result of the measurement of ATP level of the back skin of mice irradiated by UVB and HaCaT cells provided by the present invention; Fig. 9 The present invention provides changes in mitochondrial distribution after UVB irradiation of HaCaT cells;
[0058] Fig.10 is the level of mtROS after UVB irradiation of HaCaT cells provided by the present invention;
[0059] Fig.11 The change of mitochondrial membrane potential after UVB irradiation of HaCaT cells provided by the present invention;
[0060] Fig.12 The GEO (GSE138800) provided by the present invention is before and after UVB irradiation (control group, UVB 20mJ / cm 2 Group) The differential expression of HaCaT cell mRNA was cross-analyzed with mitochondrial-related genes in the Amigo 2 database;
[0061] Fig.13 The GEO (GSE138800) provided by the present invention is before and after UVB irradiation (control group, UVB 40mJ / cm 2 Group) The differential expression of HaCaT cell mRNA was cross-analyzed with mitochondrial-related genes in the Amigo 2 database;
[0062] Fig.14 The present invention provides the changes in the expression of mitochondrial apoptosis-related molecules after UVB irradiation of the back skin of mice;
[0063] Fig.15 The results of the expression changes of mitochondrial apoptosis-related molecules after UVB irradiation of the back skin of mice provided by the present invention;
[0064] Fig.16 The present invention provides the expression changes of mitochondrial apoptosis-related molecules after UVB irradiation of HaCaT cells;
[0065] Fig.17It is the result of the expression change of mitochondrial autophagy-related molecules after UVB irradiation of the back skin of mice provided by the present invention;
[0066] Fig.18 The co-localization result of FUNDC1 and COX4 detected after UVB irradiation of the back skin of mice provided by the present invention;
[0067] Fig.19 The co-localization result of LC3B and COX4 detected after UVB irradiation of the back skin of mice provided by the present invention;
[0068] Fig. 20 The results of expression of mitochondrial autophagy-related molecules after irradiation of mouse HaCaT cells with different doses of UVB provided by the present invention;
[0069] Fig.21 The expression change results of mitochondrial autophagy-related molecules at different time points after UVB irradiation of HaCaT cells provided by the present invention;
[0070] Fig. 22 It is the result of detecting the co-localization of FUNDC1 and COX4 after UVB irradiation of HaCaT cells provided by the present invention;
[0071] Fig.23 The co-localization result of LC3B and COX4 detected after UVB irradiation of HaCaT cells provided by the present invention;
[0072] Fig.24 The results of the expression changes of FUNDC1 in the non-exposed part and the exposed part of human skin tissue provided by the present invention;
[0073] Fig.25 This is a schematic diagram of the hu6-mcs-cmv-puromycin lentiviral vector encoding FUNDC1 short hairpin RNA provided by the present invention;
[0074] Fig.26 The FUNDC1 overexpression provided by the present invention enhances the result of UVB-induced photodamage;
[0075] Fig. 27 It is the result of the overexpression of FUNDC1 provided by the present invention leading to mitochondrial depletion through indiscriminate elimination of damaged and undamaged mitochondria and ATP depletion;
[0076] Fig.28 The FUNDC1 silencing provided by the present invention alleviates the light damage caused by UVB;
[0077] Fig.29 It is the result of FUNDC1 silencing provided by the present invention rescuing mitochondrial damage and depletion;
[0078] Fig.30This is the Western blotting result after FUNDC1 silencing provided by the present invention. DETAILED DESCRIPTION
[0079] The following is a detailed description with reference to the accompanying drawings.
[0080] The main reagents used in the present invention are: 4% paraformaldehyde (China, Solebao Company); glass slides and cover glass (China, Solebao Company); wax-dewaxing transparent agent (China, Nanchang Yulu); hematoxylin stain (China, Sevier Company); neutral gum (China, Sevier Company); enhanced ATP detection kit (China, Biyuntian Biotechnology Company); COX4 antibody (United States, Santa Company); γH2Ax antibody (United States, Immunoway Company); OCT embedding agent (Germany Lecia Company); PBS buffer (United States, Biosharp Company); Triton X-100 (China, Solebao Company); bovine serum albumin BSA (China, Solebao Company); anti-fluorescence attenuation mounting medium (China, Solebao Company); DAPI (United States, Cell Signaling Technology Company); goat anti-mouse IgG H&L (Alexa 488) (Abcam, USA); goat anti-rabbit IgG H&L (Alexa 594) (Abcam, USA); Penicillin / Streptomycin Antibiotic Solution (Biological Industries, Israel); DMEM High Glucose Medium (Xiaopeng Biotechnology, China); Trypsin (Biological Industries, Israel); Fetal Bovine Serum (Xiaopeng Biotechnology, China); CCK8 (Yisheng Bio, China); DCFH-DA (Merck, Germany); YO-PRO-1 / PI Cell Apoptosis and Necrosis Detection Kit (Biyotime Biotechnology, China); Mito-Tracker Red CMXRos (mitochondrial red fluorescent probe, high purity) (Biyotime Biotechnology, China); MitoSOX Red Mitochondrial Superoxide Indicator (mitochondrial superoxide red fluorescent probe) (Yisheng Bio, China); Mitochondrial membrane potential detection kit (JC-1) (Biyuntian Biotechnology, China); Immunohistochemistry ultrasensitive SP kit (Fuzhou Maixin Biotechnology Development Co., Ltd., China); FUNDC1 antibody, BNIP3 antibody, PINK1 antibody, Parkin antibody (rabbit polyclonal antibody) (Immunoway, USA); LC3B antibody (rabbit monoclonal antibody) (Abcam, USA); cytochrome c antibody, Cleaved-Caspase 3 antibody (rabbit monoclonal antibody) (Cell Signaling, USA) Technology Company); Bcl2 antibody, Bax antibody (rabbit monoclonal antibody) (Abmart, China); RIPA strong lysis buffer (Beyotime Biotechnology, China); cocktail phosphatase inhibitor (Abmole, China); PMSF (Beyotime Biotechnology, China); 3 mm grinding beads (Sevier, China); BCA kit (Beyotime Biotechnology, China); SDS-PAGE loading buffer (reducing type) (Kangwei Century Biotechnology, China); SDS-PAGE gel kit (Biosharp Biotechnology, China); polyacrylamide The upper layer includes gum red dye (Sevier, China); anhydrous ethanol (McLean Reagent, China); pre-stained colored protein marker (Pulai Biotech, China); glycine (Solarbio, China); Tris (Solarbio, China); SDS (Solarbio, China); methanol (McLean Reagent, China); PVDF membrane (Millipore, USA); skim milk powder (Solarbio, China); ECL luminescent solution (Biyuntian Biotechnology, China); 10×TBST solution (Solarbio, China); WB-specific primary and secondary antibody diluent (Aibixin Biotech, China);GAPDH antibody (Aibixin Biotechnology, China); peroxidase-labeled goat anti-rabbit secondary antibody (Proteintech, China); peroxidase-labeled goat anti-mouse secondary antibody (Proteintech, China); sodium citrate antigen retrieval solution (50×) (Solarbio, China); DAB color development kit (MXB Maixin Biotechnology, China); ready-to-use histochemistry kit (MXB Maixin Biotechnology, China);
[0081] The main instruments used in the present invention are: -80°C deep-freezer (Thermo Corporation, USA); -20°C low-temperature refrigerator (Siemens, Germany); 4°C refrigerator (Thermo Corporation, USA); micropipette (Rainin Corporation, USA); dermatoscope (ILLUCO IDS1100, South Korea); embedding machine (Wuhan Junjie Dianzi Co., Ltd., China); paraffin tissue slicer (Leica, Germany); frozen slicer (Leica, Germany); optical microscope (Olympus, Japan); Sorvall ST40R desktop refrigerated centrifuge (Thermo Corporation, USA); UV 801KL (Waldmann, Germany); vortex shaker (Qilin Bell Instrument, China); desktop centrifuge (Thermo, USA); microplate reader (BioTek, USA); deionized water preparation system (Millipore, USA); confocal microscope (Olympus, Japan); constant temperature water bath (Thermo, USA); constant temperature carbon dioxide cell culture incubator (Thermo, USA); biosafety bench (Thermo, USA); cell counter (Thermo, USA); Cytation 5 live cell imaging analysis system (BioTek, USA); chemiluminometer (PerkinElmer, USA); protein gel electrophoresis tank, electrophoresis instrument and transfer tank (Bio-Rad, USA); horizontal shaker (Qilin Bell Instrument, China); chemiluminescence image analysis system (Tianneng, China); microwave oven (Supor, China).
[0082] Mouse source and modeling: Wild-type C57BL / 6 female mice, 6-8 weeks old, 16-18g, a total of 15 mice, (Shenyang Baoliheng Biotechnology Co., Ltd., Shenyang, China). The back skin of the mice was shaved and irradiated with UVB. The back skin of the mice was observed 24h and 72h after irradiation, and the clinical manifestations of photodamage to the back skin of the mice were observed. The skin photodamage model was successfully established, and the skin tissue was collected for subsequent experiments. The mouse skin acute photodamage model was established. It has passed the experimental animal welfare and ethics review of China Medical University (KT2019051).
[0083] Cell source and modeling: Human immortalized epidermal cells (HaCat) (Cell Bank of Type Culture Collection of Chinese Academy of Sciences, Shanghai, China).
[0084] Source of human skin tissue: Subjects were recruited and skin tissues from exposed and non-exposed parts were collected by biopsy. Human skin tissues from exposed and non-exposed parts were obtained from the Department of Dermatology, the First Affiliated Hospital of China Medical University, and obtained the ethics review approval of the Medical Science Research Ethics Committee of the First Affiliated Hospital of China Medical University (2023-308-2). A total of 10 samples from 10 independent patients were obtained; 5 unexposed skin samples and 5 exposed skin samples. The skin samples were taken from patients who underwent lesion resection at the First Affiliated Hospital of China Medical University. The details are shown in Table 1, which records the age, gender, and body part of each sample.
[0085] UVB irradiated HaCat cells and primary keratinocytes to establish a cell acute light damage model. The cell lines were supplemented with 10% fetal bovine serum (FBS, Biological Industries) and penicillin (100 μml -1 )-Streptomycin (100 μg ml -1 The cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) from (Biological Industries) at 37°C in a humidified incubator with 5% CO2.
[0086] After irradiation, fresh medium without FBS was used instead of PBS for subsequent experiments. Unless otherwise stated, the UVB treatment dose for mice and HaCaT was 200 mJ / cm 2 and 30mJ / cm 2 .
[0087] The present invention uses C57BL / 6 mice, HaCat cells, human primary keratinocytes and human skin specimens as research objects, and irradiates the mice and cells with UVB to clarify the following issues: ① Mitochondrial autophagy in UVB-irradiated skin tissues and cells; ② Mitochondrial pathway cell apoptosis in UVB-irradiated skin tissues and cells; ③ The relationship between FUNDC1-mediated mitophagy and mitochondrial pathway cell apoptosis and the compensatory effects of other types of mitophagy, clarifying the key role of FUNDC1 in the process of light damage. The present invention provides FUNDC1 as a drug target for screening the prevention and / or treatment of skin light damage. The active ingredients of drugs for preventing and treating skin light damage include FUNDC1 inhibitors.
[0088] Statistical methods: The experimental data of the present invention were obtained from at least three independent experiments, and the results were expressed as mean ± standard deviation. The images were quantitatively analyzed using Image J (National Institutes of Health, USA); GraphPad Prism 8.0 was used for one-way analysis of variance (one-way, ANOVA) and Tukey's post hoc test; SPSS software variance analysis was used for multiple comparisons, and P < 0.05 was considered statistically significant. GraphPad Prism 8.0 and Adobe Illustrator were used for drawing.
[0089] Example 1
[0090] This example provides the following method to study UVB-induced skin photodamage.
[0091] 1. Establishment of UVB-induced photodamage model of C57BL / 6 mouse back skin
[0092] Methods: Fifteen mice were divided into three groups. The back skin of the mice was shaved (exposing 2 cm×2 cm of the back skin of the mice), and the back skin was irradiated with UVB. UVB phototherapy device UV801KL device (emission range 290-315 nm; Waldmann, Germany) was used for UVB irradiation. The mice not irradiated with UVB were set as blank control group (also represented as control, cont or control in the figure). The back skin of the mice was observed 24h and 72h after irradiation, and gross pictures were taken. The dermatoscope (ILLUCO IDS1100, South Korea) was used to collect pictures with flat light (non-polarized light) and polarized light, and the clinical manifestations of skin photodamage such as erythema, blisters, erosions, scabs, and capillary dilation on the back skin of the mice were observed.
[0093] 2. Observation of pathological changes in mouse skin tissue by HE staining
[0094] Human and mouse skin tissues were fixed with formalin, embedded in paraffin, cut into 7 μm sections, and mounted; tissue sections were dewaxed and stained with hematoxylin and eosin (HE).
[0095] The specific operation is as follows: Use a tissue slicer to slice the embedded mouse paraffin tissue blocks with a thickness of 5μm; treat with wax dewaxing transparent agent I for 10 minutes, treat with wax dewaxing transparent agent II for 10 minutes, treat with anhydrous ethanol I for 5 minutes, treat with anhydrous ethanol II for 5 minutes, 95% ethanol for 5 minutes, 85% ethanol for 5 minutes, 75% ethanol for 5 minutes, and wash with PBST 3 times, each time for 5 minutes; place the slices in hematoxylin stain solution for 15 minutes; rinse with PBST for 10 minutes; differentiate with 1% hydrochloric acid ethanol for 5 to 30 seconds; rinse with PBS for 3 minutes and then use weak alkaline aqueous solution to return blue for 60 seconds, rinse with running water for 10 minutes; place in eosin stain solution for staining for 10 minutes; treat with 75% ethanol for 5 minutes, 85% ethanol for 5 minutes, 95% ethanol for 5 minutes, anhydrous ethanol II for 5 minutes, anhydrous ethanol I for 5 minutes, treat with wax dewaxing transparent agent II for 10 minutes, and treat with wax dewaxing transparent agent I for 10 minutes; seal the slices with neutral gum; observe the tissue pathological changes under a microscope and take pictures.
[0096] 3. Determination of ATP levels using the enhanced ATP kit
[0097] Sample preparation: For tissues, add 100 μl of lysis buffer for every 20 mg of tissue, and then homogenize with a glass homogenizer. Adequate homogenization can ensure that the tissue is completely lysed. Take the supernatant for subsequent determination. For cells, remove the culture medium and add 200 μl of lysis buffer to each well of a 6-well plate. After lysis, centrifuge at 4°C, 12,000 g for 5 minutes, and take the supernatant for subsequent determination.
[0098] Draw a standard curve based on the ATP standard solution: melt the reagent to be used in an ice bath, dilute the ATP standard solution with ATP detection lysis buffer to an appropriate concentration gradient, and perform initial detection in subsequent experiments at concentrations of 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 μM. According to the concentration of ATP in the sample, adjust the concentration range of the standard appropriately to establish a standard curve.
[0099] Preparation of ATP detection working solution: 100 μl of ATP detection working solution is required for each sample or standard. Take an appropriate amount of ATP detection reagent and dilute the ATP detection reagent with ATP detection reagent diluent at a ratio of 1:4.
[0100] Determination of ATP concentration: a. Add 100 μl of ATP detection working solution to the detection well. Leave at room temperature for 5 minutes to consume all the background ATP; b. Add 20 μl of sample or standard to the detection well, quickly mix with a gun, and after 2 seconds, use a chemiluminescence instrument (Victor X2, PerkinElmer, USA) to measure the RLU value and calculate the ATP concentration in the sample based on the standard curve.
[0101] 4. Immunofluorescence of frozen tissue sections
[0102] Mark the slides in advance and place the sample tray in the freezing slicer; cut the tissue into 0.5cm×0.5cm size, wash it in PBS, dry it with paper, and fix it in paraformaldehyde for 20 minutes; drop OCT embedding agent into the embedding box, place the tissue vertically in the box, adjust the direction of the tissue, and add some OCT embedding agent until it is completely solidified and can be stored at -80℃.
[0103] The samples were placed from -80℃ to -20℃ 2h in advance to balance the sample temperature; the slides should be placed at room temperature. If they are placed at -20℃ for a long time, the tissue will not be able to adhere; sectioning (Leica CM1950 cryostat, Wetzlar, Germany): the section thickness is 6μm, and the sections are directly placed in room temperature PBS. The OCT embedding agent will automatically dissolve in PBS; wash with PBS 3 times, 5min each time, wipe off the moisture on the edges and back, and draw circles around the tissue with a tissue pen; membrane permeabilization: prepare 0.2% Triton solution, room temperature for 20min; wash with PBS 3 times, 5min each time; block: prepare 5% BSA solution, room temperature for 1h; use 1% BSA according to the instructions The primary antibody was prepared with the solution and incubated at 4°C overnight; the sections were washed with PBS for 3 times, 5 min each time; the secondary antibody was prepared with 1% BSA solution according to the instructions and incubated at room temperature for 1 h; the sections were washed with PBS for 3 times, 5 min each time; the DAPI dye was prepared with 1% BSA solution according to the instructions and incubated at room temperature for 30 min; the sections were washed with PBS for 3 times, 5 min each time, and the PBS outside the specimen was wiped off with filter paper; the sections were mounted with anti-fluorescence attenuation mounting media, placed in a light-proof box, and imaged with a confocal microscope (Olympus FV1000 IX81, 40×) after drying.
[0104] 5. HaCaT cell culture and passaging
[0105] Take out the cells from the incubator and observe under a microscope. If the cell density reaches 80-90%, they can be subcultured. Discard the supernatant and gently wash the cells twice with PBS. Add trypsin in a volume suitable for the culture flask or dish, place in a 37°C incubator for digestion for 5 minutes, and observe the digestion under a microscope. If most of the cells have fallen off or become round, quickly take them back to the operating table and add an equal volume of culture medium containing 10% fetal bovine serum to terminate the digestion reaction. Transfer the cell suspension to a 15ml centrifuge tube and incubate at 1000rpm for 5min. Discard the supernatant and re-add 1-2ml complete culture medium. Use a pipette to gently blow until the cells are resuspended. Re-inoculate the cell suspension into the culture flask or dish, subculture at a ratio of 1:3, add an appropriate amount of complete culture medium, shake crosswise, and place in a 37°C, 5% CO2 incubator.
[0106] 6. Establishment of HaCaT cell light damage model by cell irradiation
[0107] Cell counting: When the cell fusion reaches 80-90%, it can be used for plating for subsequent experiments. After cell digestion, take 1 ml of complete medium to resuspend, and take 10 μl to count with a cell counter; Cell plating: According to the needs of subsequent experiments, choose culture dishes or culture plates of different sizes, and inoculate cells according to the fusion needs to ensure that the cell density between different groups is basically the same. Put the inoculated culture dishes or culture plates into the incubator for continued culture; Cell illumination: 24 hours after plating, observe the cell adhesion and cell fusion under a microscope. When the fusion required for different experiments is reached, discard the supernatant, wash the cells twice with PBS buffer, add 4°C pre-cooled PBS buffer, the volume of PBS buffer is converted according to the size of the culture bottom area, 100 μl per square centimeter, place the cells under a UV lamp, the distance between the lamp and the cells is 15 cm, and perform UVB (10-50 mJ / cm 2 ) irradiation, after the irradiation, the PBS was discarded, serum-free culture medium was added to stop the growth of cells, and the cells were placed in a 37°C, 5% CO2 incubator until different time points needed to be detected in different experiments.
[0108] 7. CCK8 assay for cell viability
[0109] Cell counting; cell plating: digest cells, collect cells by centrifugation, resuspend in complete medium, and inoculate in 24-well plates (2-8)×10 4 / well, set 3 sub-wells for each group, shake evenly in a cross shape, and place in an incubator overnight; cell illumination: when the cell confluence reaches 80-90%, set the UVB dose to 10, 20, 30, 40, 50 mJ / cm 2 After irradiation, the cells were placed back in the incubator (37°C, 5% CO2); CCK8 cell viability was detected: after 24 hours of culture in the incubator, the cell confluence and cell morphology were observed under a microscope, and photographs were taken under an optical microscope. The culture medium was removed, and the cells were washed twice with PBS buffer. 500 μl of culture medium containing CCK8 (450 μl of culture medium + 50 μl of CCK8 reagent) were added and cultured in a CO2 incubator for 1 hour; the culture medium containing CCK8 was transferred to a 96-well plate, and the absorbance (OD) at a wavelength of 450 nm was detected; Statistics: the cell survival rate of the blank control group was defaulted to 100%, and the cell survival rates of the remaining groups were calculated based on the absorbance.
[0110] 8. DCFH-DA determination of intracellular reactive oxygen species (ROS) levels
[0111] Cell counting; Cell plating: digest and centrifuge to resuspend cells, inoculate in 6-well plates, (8-32)×104 / well, shake evenly in a cross shape, and place in an incubator overnight; cell irradiation: when the cell confluence reaches 60-70%, use the same irradiation method as above at 30mJ / cm 2 Irradiation: After irradiation, the cells were placed back in the incubator; DCFH-DA staining: After culturing in the incubator for 1 hour, the cell confluence and cell morphology were observed under a microscope, the culture medium was removed, the cells were rinsed with PBS buffer, and the accumulation of intracellular ROS was determined by 2,7-dichlorofluorescein diacetate (DCFH-DA) staining, that is, the cells were placed in 1 μM DCFH-DA, incubated at 37°C in the dark for 20 minutes, washed three times with PBS buffer, and complete culture medium at room temperature was added; Imaging: The Cytation 5 live cell imaging analysis system (BioTek, USA) was used for observation and photography, and Gen 5 (BioTek, USA) was used to analyze the images.
[0112] 9. YO-PRO-1 / PI fluorescence cell double staining experiment to detect cell apoptosis and necrosis
[0113] Cell counting; Cell plating: digest and centrifuge to resuspend cells, inoculate in 12-well plates, (4-16)×10 4 / well, shake evenly in a cross shape, and place in an incubator overnight; cell irradiation: when the cell confluence reaches 60-70%, use the same irradiation method as above at 30mJ / cm 2 Irradiation: After irradiation, the cells were put back into the incubator; YO-PRO-1 / PI staining: After 6 hours of culture in the incubator, the cell confluence and cell morphology were observed under a microscope, the culture medium was removed, the cells were rinsed with PBS buffer, and the YO-PRO-1 / PI working solution was prepared according to the instructions. Each 1 ml of the detection working solution contained 1 μl of YO-PRO-1 (1000×), 1 μl of PI (1000×), and 998 μl of detection buffer. After incubation at 37°C in the dark for 20 minutes, the cells were washed 3 times with PBS buffer and complete culture medium at room temperature was added; Imaging: Observation and photography were performed using the Cytation 5 live cell imaging analysis system.
[0114] 10. Cell Immunofluorescence
[0115] Cell counting; Cell plating: Place the 24-well cell plate on a 6 cm culture dish, add the digested centrifuged and resuspended cells, shake evenly, and place in an incubator overnight; Cell illumination: When the cell confluence reaches 60%, use the same illumination method as above at 30 mJ / cm 2Irradiation, after irradiation is completed, put it back into the incubator; fixation: after 6 hours, take out the culture dish, take out the cell slide from the culture dish, put it in a 24-well plate with the cell side facing up, wash once with PBS buffer, fix with paraformaldehyde for 15 minutes (dry in room for 10 minutes); wash 3 times with PBS, 3 minutes each time; membrane permeation: 0.5% Triton, 15 minutes; 5% BSA blocking for 2 hours; prepare primary antibody with 1% BSA according to the instructions, incubate at room temperature in the dark for 2 hours; wash 3 times with PBS buffer, 3 minutes each time; prepare DAPI dye according to the instructions, room temperature for 30 minutes; wash 3 times with PBS, 3 minutes each time; prepare slides, drop anti-fluorescence attenuation sealing agent on the slide, carefully take out the slide, turn it upside down on the slide with the cell side facing down, and apply nail polish sealing around it after drying, then put it in a black light-proof box, image and take pictures with a confocal microscope.
[0116] 11. Mito-Tracker Red CMXRos cell fluorescence staining to detect the morphology and distribution of mitochondria in cells
[0117] Cell counting; Cell plating: digest and centrifuge to resuspend the cells, inoculate the cells in a 12-well plate, (4-16)×10 4 / well, shake evenly in a cross shape, and place in an incubator overnight; cell irradiation: when the cell confluence reaches 60-70%, use the same irradiation method as above at 30mJ / cm 2 Irradiation: After irradiation, put the cells back into the incubator; Mito-Tracker Red CMXRos staining: After 12 hours of culture in the incubator, observe the cell confluence and cell morphology under a microscope, remove the culture medium, rinse the cells with PBS buffer, prepare Mito-Tracker Red CMXRos working solution according to the instructions, take an appropriate amount of 200μM Mito-Tracker RedCMXRos storage solution, add it to the cell culture medium at a ratio of 1:10000 to make a final concentration of 20nM, incubate at 37℃ in the dark for 30 minutes, and wash three times with PBS; prepare DAPI dye according to the instructions and stain at room temperature for 30 minutes; wash with PBS three times, 5 minutes each time, and add complete culture medium at room temperature; Imaging: Observe and take pictures using the Cytation 5 live cell imaging analysis system.
[0118] 12. Mitochondria superoxide red fluorescent probe (MitoSOX Red Mitochondrial Superoxide Indicator) detects ROS levels in mitochondria
[0119] Cell counting; Cell plating: digest the centrifuged and resuspended cells and inoculate them in a 12-well plate, (4-16)×10 4 / well, shake evenly in a cross shape, and place in an incubator overnight; cell irradiation: when the cell confluence reaches 60-70%, use the same irradiation method as above at 30mJ / cm 2 Irradiation, after irradiation, put back into the incubator; MitoSOX Red mitochondrial superoxide indicator staining: after culturing in the incubator for 3 hours, observe the cell confluence and cell morphology under a microscope, remove the culture medium, rinse the cells with PBS, prepare MitoSOX Red working solution according to the instructions, dilute MitoSOX Red 5mM stock solution with HBSS solution at a ratio of 1000 to a final concentration of 5μM, incubate with MitoSOX Red mitochondrial superoxide indicator with a final concentration of 5μM at 37℃ in the dark for 10 minutes, and then wash with PBS three times; prepare DAPI dye according to the instructions and stain at room temperature for 30 minutes; wash with PBS three times, 5 minutes each time, and add complete culture medium at room temperature; imaging: observe and take pictures using Cytation 5 live cell imaging analysis system.
[0120] 13. Mitochondrial membrane potential detection kit (JC-1) to detect mitochondrial membrane potential
[0121] Cell counting; Cell plating: digest the centrifuged and resuspended cells and inoculate them in a 12-well plate, (4-16)×10 4 / well, shake evenly in a cross shape, and place in an incubator overnight; cell irradiation: when the cell confluence reaches 60-70%, use the same irradiation method as above at 30mJ / cm 2Irradiation, after irradiation is completed, put it back into the incubator; JC-1 staining: after 6 hours of incubation in the incubator, observe the cell confluence and cell morphology under a microscope, remove the culture medium, rinse the cells with PBS buffer, prepare JC-1 working solution according to the instructions, dilute JC-1 at a ratio of 8 ml ultrapure water for every 50 μl of JC-1 storage solution (200×), and then add 2 ml of JC-1 staining buffer (5×), mix well to obtain JC-1 staining working solution, and incubate at 37°C in the dark for 20 minutes; during the incubation period, prepare an appropriate amount of JC-1 staining buffer (1×) at a ratio of 4 ml of distilled water for every 1 ml of JC-1 staining buffer (5×), and place it in an ice bath; after the incubation at 37°C, remove the supernatant, wash twice with JC-1 staining buffer (1×), and add complete culture medium at room temperature; imaging: observe and take pictures using the Cytation 5 live cell imaging analysis system. When the mitochondrial membrane potential (MMP) is high, JC-1 aggregates in the mitochondrial matrix to form polymers (J-aggregates), which can produce red fluorescence. When the mitochondrial membrane potential is low, JC-1 cannot accumulate in the mitochondrial matrix, and JC-1 is a monomer that can produce green fluorescence.
[0122] 14. Enrichment of differential mRNA using the public database GEO
[0123] mRNA data were loaded from the public database GEO (https: / / www.ncbi.nlm.nih.gov / geo / query / acc.cgi?acc=GSE138800) and analyzed before and after UVB irradiation (including blank control group, UVB 20mJ / cm 2 and UVB: 40mJ / cm 2 The difference of HaCaT cell mRNA sequence (mRNA-seq) between the two groups was analyzed. The Amigo 2 database (http: / / amigo.geneontology.org / amigo / landing) was used to retrieve genes related to mitochondrial biogenesis, mitochondrial fission, mitochondrial fusion, and mitophagy. The above-mentioned differential mRNA sequences from the GEO database were intersected with the mitochondrial-related genes in the Amigo 2 database, and were statistically analyzed using Graphpad Prism 8.0. The selected genes were enriched by KEGG using the R package "ggplot2" in the R language.
[0124] The following are the test results.
[0125] 1. Gross Photographs and Dermoscopic Observations of UVB-Induced Photodamage in Mouse Skin
[0126] At 200mJ / cm 2C57BL / 6 mice were irradiated with UVB, and the back skin of each group of mice was photographed, examined by dermoscopy, and stained with hematoxylin / eosin at 24h and 72h after irradiation.
[0127] Depend on Figure 1 It can be seen that compared with the blank control group, there was no significant change in the back skin after 24 hours of irradiation, but obvious erythema and scaling appeared after 72 hours of irradiation, and even erosion, ulceration and scab appeared ( Figure 1 A, gross image of the mouse back skin). In the non-polarized light results of the dermatoscope, the skin damage caused by UVB was slightly thickened at 24 hours, and there were obvious erythema, scaling and scabs at 72 hours of irradiation; in the polarized light results, the skin showed obvious capillary dilation at 24 hours of irradiation, and the capillary dilation was further aggravated at 72 hours of irradiation, with obvious erythema, scaling and scabs ( Figure 1 B, Non-polarized light and polarized light dermoscopy results).
[0128] Figure 2 Results To further verify the successful establishment of the UVB-induced photodamage model of C57BL / 6 mouse back skin, the back skin of the mice was taken for HE staining 24h and 72h after UVB irradiation ( Figure 2 A, HE staining results). Compared with the blank control group, the epidermal thickness of the mouse skin increased significantly after 24 hours of irradiation, and the epidermal thickening was more significant after 72 hours of irradiation ( Figure 2 A and Figure 2 B, epidermal thickening after UVB treatment), and scales and scabs appeared, indicating that skin photodamage is time-dose dependent on UVB irradiation. In addition, a large number of inflammatory cells infiltrated the dermis at 72 hours. Based on the above gross photos, dermoscopy and HE staining results, it can be proved that the UVB-induced photodamage model of the back skin of C57BL / 6 mice was successfully established.
[0129] 2. CCK8 assay to determine the effect of different doses of UVB on the survival rate of HaCaT cells
[0130] In order to clarify whether the degree of damage of HaCaT cells by different doses of UVB is dose-dependent, in this example, HaCaT cells in the logarithmic growth phase were plated in a 24-well plate. After the cell density reached 80-90%, the HaCaT cells were exposed to different doses of UVB (10, 20, 30, 40, 50 mJ / cm 2 ) were treated with light, and the cell viability was detected by CCK8 method 24 hours after light treatment. Figure 3 shown.
[0131] Figure 3 A is the survival result of HaCaT cells after UVB irradiation under light microscope. Figure 3The c in A represents the unexposed group, and 10, 20, 30, 40, and 50 represent 10, 20, 30, 40, and 50 mJ / cm, respectively. 2 Lighting treatment. Figure 3 B is a statistical graph of HaCaT cell survival rate after UVB irradiation, with different doses of UVB on the horizontal axis and cell survival rate on the vertical axis. The results are expressed as mean ± standard deviation, N = 3. P < 0.05 indicates that the difference is statistically significant. Scale bar 100 μm. Figure 3 In B, when the UVB dose is 10 and 20 mJ / cm 2 When the UVB dose was 30, 40, and 50 mJ / cm 2 When the UVB dose reached 40 and 50 mJ / cm, the survival rates of HaCaT cells decreased to 60%, 22% and 16%, respectively. 2 When the concentration of 30 mJ / cm2 was 400 μg / cm3, there were almost no surviving cells under the microscope. 2 Conduct subsequent experiments.
[0132] 3. DCFH-DA determination of intracellular ROS levels
[0133] To clarify the effect of UVB irradiation on intracellular ROS levels, DCFH-DA staining was performed 1 h after UVB irradiation of HaCaT cells. Green fluorescence reflects the intracellular ROS level. Figure 4 shown. Figure 4 A is the ROS level in HaCaT cells after UVB irradiation under a fluorescence microscope; Figure 4 B is a statistical graph of ROS levels in HaCaT cells after UVB irradiation. The results show that the green fluorescence intensity increased significantly, indicating that the ROS level in HaCaT cells increased after UVB irradiation. The results are expressed as mean ± standard deviation, N = 3. P < 0.05 indicates that the difference is statistically significant. Scale bar 200 μm.
[0134] 4. YO-PRO-1 / PI fluorescence cell double staining experiment to detect cell apoptosis and necrosis
[0135] To clarify the level of apoptosis and necrosis after UVB irradiation, YP-PRO-1 / PI staining experiment was performed 12h after UVB irradiation of HaCaT cells. Figure 5 Green fluorescence represents YP-PRO-1 / PI positive cells, indicating cell apoptosis; red fluorescence represents PI positive cells, indicating cell necrosis. Figure 5 A shows the levels of apoptosis and necrosis in HaCaT cells after UVB irradiation under a fluorescence microscope; Figure 5B is a statistical graph of apoptosis and necrosis levels in HaCaT cells after UVB irradiation. The results are expressed as mean ± standard deviation, N = 3. P < 0.05 indicates that the difference is statistically significant. Scale bar 200 μm. After UVB irradiation, the green fluorescence intensity and red fluorescence intensity were significantly increased compared with the blank group ( Figure 5 A), After UVB irradiation, the fluorescence intensity of YP-PRO-1 and PI increased significantly compared with the control group ( Figure 5 B), indicating that apoptosis and necrosis occurred in HaCaT cells after UVB irradiation.
[0136] 5.γH2Ax assay for UVB-induced nuclear damage
[0137] To clarify the extent of nuclear damage after UVB irradiation, proteins were extracted at different time points (1, 3, 6, 12, and 24 h) after UVB irradiation of HaCaT cells, and the expression level of γH2Ax was detected. Figure 6 Shown (detection results of nuclear damage of HaCaT cells irradiated by UVB). Figure 6 A: Western blot detection of γH2Ax expression level; Figure 6 B is a statistical graph of γH2Ax expression levels; Figure 6 C is the fluorescence intensity of γH2Ax in HaCaT cells after UVB irradiation under a fluorescence microscope; Figure 6 D is a statistical graph of the fluorescence intensity of γH2Ax in HaCaT cells after UVB irradiation. The results are expressed as mean ± standard deviation, N = 3. P < 0.05 is considered statistically significant. Scale bar 20 μm. After UVB irradiation, the expression level of γH2Ax was upregulated and reached a peak at 6 h ( Figure 6 A and Figure 6 B), indicating that nuclear damage occurred in HaCaT cells after UVB irradiation.
[0138] Furthermore, immunofluorescence staining of γH2Ax was performed 6 h after UVB irradiation. The green fluorescence represented the expression level of γH2Ax. Compared with the blank control group, the green fluorescence intensity increased significantly ( Figure 6 C and Figure 6 D), and they were all expressed in the nucleus, suggesting that UVB irradiation of HaCaT cells caused damage to the nucleus.
[0139] The above results of cell survival rate, intracellular ROS level, cell apoptosis and necrosis level and cell nuclear damage level proved that under UVB of 30mJ / cm 2 The photodamage model of HaCaT cells was successfully established under these conditions.
[0140] 6. UVB induces mitochondrial reduction in mouse skin and HaCaT cells
[0141] In order to determine the level of mitochondrial damage in mouse skin after UVB irradiation, skin tissues were obtained 72 h after UVB irradiation for OCT embedding and frozen sectioning. Figure 7 and Figure 8 As shown, this example detects the expression level of mitochondrial protein COX4 by tissue immunofluorescence staining, wherein: Figure 7 The green fluorescence represents the fluorescence intensity of COX4, and the blue fluorescence represents DAPI.
[0142] Figure 7 The results of the detection of COX4 levels in the back of UVB-irradiated mice and HaCaT cells under a confocal microscope. Figure 7 A is the COX4 level in the back skin of UVB-irradiated mice. Figure 7 B is the COX4 level of HaCaT cells irradiated by UVB. Figure 8 Statistical results of the measurement of ATP levels in the back skin of UVB-irradiated mice and HaCaT cells using a fluorescent microplate reader. Figure 8 A is the ATP measurement result of the back skin of UVB-irradiated mice. Figure 8 B is the ATP measurement result of HaCaT cells irradiated by UVB. Figure 8 A and Figure 8 The horizontal axis of B is the group, and the vertical axis is the ATP content (nmol / L). The results are expressed as mean ± standard deviation, N = 5 for mice, N = 3 for cells, and P < 0.05 indicates that the difference is statistically significant. Scale bar 20 μm.
[0143] Figure 7 and Figure 8 The results showed that compared with the non-irradiated group, the expression of COX4 in the back skin and HaCaT cells of mice after UVB irradiation was significantly downregulated, and the ATP level in the back skin and HaCaT cells of mice decreased, indicating a reduction in mitochondria, and mitochondrial damage was caused after UVB irradiation of the back skin and HaCaT cells of mice.
[0144] 7. UVB induces a decrease in ATP levels in mouse skin and HaCaT cells
[0145] To explore the skin mitochondrial damage caused by UVB, this example detected the changes in ATP levels in mouse skin and HaCaT cells after UVB irradiation. The results are as follows: Figure 8 Shown (UVB irradiated mouse back skin and ATP level measurement in HaCaT cells). Figure 8 A is the detection of ATP level in the back skin of UVB-irradiated mice by fluorescence microplate reader; Figure 8 B is the ATP level of HaCaT cells irradiated with UVB detected by fluorescence microplate reader. The results are expressed as mean ± standard deviation, N = 5 for mice, N = 3 for cells, and P < 0.05 indicates statistically significant differences.
[0146] UVB irradiation of mouse skin ( Figure 8 A) and HaCaT cells ( Figure 8 B), ATP levels decreased, indicating that UVB irradiation of the skin caused damage to mitochondrial function, affecting its energy metabolism function.
[0147] 8. UVB causes abnormal mitochondrial distribution in HaCaT cells
[0148] In order to clarify the changes in mitochondrial distribution of HaCaT cells after UVB irradiation, in this example, Mitotracker Red CMXROS was used to perform mitochondrial staining 12 hours after UVB irradiation of the cells. Fig. 9 In (Changes in the distribution of mitochondria in cells after UVB irradiation), red represents mitochondria, and the red fluorescence intensity represents the changes in mitochondrial membrane potential. Fig. 9 The results showed that the red fluorescence intensity was inversely proportional to the mitochondrial membrane potential. Fig. 9 A shows that mitochondria are distributed at two poles along the long axis of the nucleus after UVB irradiation of HaCaT cells under a fluorescence microscope. Blue represents DAPI and red represents mitochondria. Fig. 9 B is a statistical graph of red fluorescence after UVB irradiation of HaCaT cells. Fig. 9 C is a statistical diagram of the length of mitochondria distributed along the nucleus after UVB irradiation of HaCaT cells. The results are expressed as mean ± standard deviation, N = 3, P < 0.05 indicates that the difference is statistically significant, scale bar 200 μm.
[0149] The mitochondria in the blank control group were evenly distributed around the nucleus, while after UVB irradiation, the mitochondria were distributed at two poles along the long axis of the nucleus ( Fig. 9 A and Fig. 9 C), and after UVB irradiation, the red fluorescence intensity was enhanced compared with the control group ( Fig. 9 B), indicating that mitochondrial membrane potential decreased after UVB irradiation.
[0150] 9. UVB leads to an increase in the level of mtROS in HaCaT cells
[0151] In order to clarify the level of mtROS in HaCaT cells after UVB irradiation, in this example, mtROS staining was performed using MitoSOXRed 3 h after UVB irradiation. The red fluorescence represents mtROS. Fig.10 shown. Fig.10 A is the mtROS fluorescence intensity of HaCaT cells after UVB irradiation under a fluorescence microscope. Blue represents DAPI and red represents mtROS. Fig.10B is a statistical graph of mtROS levels after UVB irradiation of HaCaT cells. The results are expressed as mean ± standard deviation, N = 3, P < 0.05 indicates that the difference is statistically significant, and the scale is 200 μm. The results show that after UVB irradiation, the red fluorescence intensity is significantly enhanced, indicating that mtROS increases significantly after UVB irradiation.
[0152] 10.UVB causes a decrease in mitochondrial membrane potential in HaCaT cells
[0153] In order to clarify the changes in mitochondrial membrane potential of HaCaT cells after UVB irradiation, this example used JC-1 staining 6 hours after UVB irradiation. Fig.11 Shown (Changes in mitochondrial membrane potential after UVB irradiation of HaCaT). Fig.11 A shows the changes in mitochondrial membrane potential detected by JC-1 after UVB irradiation of HaCaT cells under a fluorescence microscope. Red represents polymers and green represents monomers. Fig.11 B is a statistical graph of changes in mitochondrial membrane potential detected by JC-1 after UVB irradiation of HaCaT cells. The results are expressed as mean ± standard deviation, N = 3, P < 0.05, the difference is statistically significant, scale bar 200 μm.
[0154] The results showed that after UVB irradiation, the red fluorescence intensity decreased and the green fluorescence intensity increased ( Fig.11 A), the ratio of JC-1 monomer / polymer increased ( Fig.11 B), indicating that mitochondrial membrane potential depolarized after UVB irradiation.
[0155] 11. Public database GEO enriched differential mRNA
[0156] The photodamage model established based on UVB irradiation of the back skin of mice and HaCaT cells induced significant mitochondrial damage results. This example further explores the role of mitochondria-related biological mechanisms in UVB-induced skin photodamage.
[0157] The Amigo 2 database contains 640 genes related to mitochondrial biogenesis, 52 genes related to mitochondrial fission, 38 genes related to mitochondrial fusion, and 37 genes related to mitophagy. To clarify the changes in gene expression, the differential mRNA (mRNA-seq) of HaCaT cells before and after UVB irradiation was analyzed using the dataset GSE138800 in the public database GEO, including the control group, UVB 20mJ / cm 2 Group and UVB 40mJ / cm 2 The obtained data were intersected with the mitochondrial related genes in the Amigo 2 database.
[0158] At 20mJ / cm2 Under UVB irradiation, a total of 213 genes related to mitochondrial biogenesis, 17 genes related to mitochondrial fission, 11 genes related to mitochondrial fusion, and 13 genes related to mitophagy were identified. KEGG was enriched in biological processes related to mitophagy, such as Fig.12 As shown, GEO (GSE138800) before and after UVB irradiation (control group, UVB 20mJ / cm 2 The differential expression of HaCaT cell mRNA in the two groups was cross-analyzed with mitochondrial-related genes in the Amigo 2 database).
[0159] At 40mJ / cm 2 Under UVB irradiation, 420 genes related to mitochondrial biogenesis, 29 genes related to mitochondrial fission, 18 genes related to mitochondrial fusion, and 25 genes related to mitophagy were identified. KEGG was enriched in biological processes related to mitophagy, such as Fig.13 As shown in (GEO (GSE138800) before and after UVB irradiation (control group, UVB40 mJ / cm 2 The differential expression of HaCaT cell mRNA in the two groups was cross-analyzed with mitochondrial-related genes in the Amigo 2 database).
[0160] All differentially expressed genes were enriched in the KEGG pathway. Fig.12 and Fig.13 These results indicate that mitochondrial damage, especially mitochondrial autophagy, plays an important and critical role in UVB-induced photodamage of HaCaT cells.
[0161] Example 2
[0162] This example provides relevant information about UVB-induced mitochondrial apoptosis and inhibition of FUNDC1-mediated mitochondrial autophagy, and repeated content is not repeated here. The results of Example 1 confirmed that mitochondrial damage and cell apoptosis occurred in the UVB-induced light damage model of mouse skin and HaCaT cells. Therefore, this example explores the important role of mitochondrial apoptosis in the cell apoptosis, and speculates that mitochondrial autophagy has a regulatory effect on mitochondrial apoptosis.
[0163] The following is the test method provided in this embodiment.
[0164] 1. Protein extraction and protein concentration detection
[0165] (1) For cells: discard the culture medium, wash with pre-cooled PBS buffer for 3 times, and use a pipette to remove the remaining PBS buffer; add an appropriate volume of pre-mixed RIPA lysis buffer (RIPA: PMSF: cocktail = 100:1:1), lyse on ice for 10 min, scrape the cells with a scraper, and transfer them to a 1.5 ml EP tube; place the EP tube in a high-speed centrifuge pre-cooled at 4°C, centrifuge at 15,000 g for 15 min, and store the supernatant at -80°C.
[0166] For tissue: separate the subcutaneous tissue of the collected skin tissue, keep only the epidermis and dermis, wash it with pre-cooled PBS buffer, cut 50mg of tissue blocks, put it in a 1.5ml EP tube, add 250μl of pre-mixed RIPA lysis solution (RIPA: PMSF: cocktail = 100: 1: 1), add grinding beads, put it in a pre-cooled tissue grinder, and grind it thoroughly until the tissue is homogenized. Take out the EP tube, put it in a pre-cooled high-speed centrifuge at 4℃, centrifuge it at 15000g for 15min, take the supernatant and store it at -80℃.
[0167] (2) Protein concentration was measured by BCA method. Preparation of working solution: According to the number of standards and samples, 50 volumes of BCA reagent plus 1 volume of Cu reagent (50:1) were used to prepare BCA working solution, and the mixture was thoroughly mixed until there was no flocculent precipitation; BSA was diluted with RIPA standard according to the instructions, and 25 mg / ml protein standard was taken, and the dilution concentration was 0.5 mg / ml. After dilution, it was stored at -40℃ for long-term storage; 0, 1, 2, 4, 8, 12, 16, and 20 μl of standard was added to a 96-well plate, and RIPA was added to make up to 20 μl, and the corresponding concentrations were 0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 mg / ml; the sample was diluted 10 times and added to a 96-well plate; 200 μl of BCA working solution was added to each well and placed at 37℃ for 30 min; the protein concentration was determined by microplate reader: the absorbance was measured at a wavelength of 562 nm, and the protein concentration was determined according to the standard curve.
[0168] 2. Western blot
[0169] (1) Cleaning the glass plate: Use a small amount of detergent to clean both sides of the glass plate, then rinse it thoroughly with tap water, and finally rinse it with distilled water, and place it vertically in a basket to dry; after cleaning the comb, wipe it with anhydrous ethanol and dry it.
[0170] (2) Pouring the gel: Clamp the aligned glass plates into the fixture and place them vertically on the rack; before pouring the gel, first inject water between the glass plates and check for leakage, select a separation gel that is suitable for the size of protein molecules, quickly pour the gel, and control the gel speed according to the concentration of APS and TEMED; after the separation gel is poured, add another layer of anhydrous ethanol on the top; when the gel solidifies, remove the upper layer of anhydrous ethanol, and then use absorbent paper to absorb the anhydrous ethanol on the glass plate; prepare concentrated gel according to the instructions, quickly pour the gel, and then insert the comb; after the gel solidifies, soak it in water and store it in a refrigerator at 4°C for use.
[0171] (3) Electrophoresis: Install the gel on the electrophoresis tank and check the fit between the gel plate and the electrode holder. Fill the inner tank with electrophoresis buffer. If the liquid level does not change within 5 minutes, it means that the gel plate and the electrode holder fit tightly and there is no leakage. The experiment can be carried out. Add electrophoresis buffer to the outer tank to submerge the bottom edge of the gel plate by 2 to 3 cm. Use a pipette to absorb the sample and slowly add the sample and protein pre-stained marker. After turning on the power, perform electrophoresis as soon as possible. Set the first stage to 80V until a straight line is formed. Set the second stage to 120V until the electrophoresis is completed. Bubbles after the power is turned on indicate a successful connection.
[0172] (4) Transfer and blocking: After the electrophoresis is completed, remove the gel sheet and prepare the materials required for electrotransfer, including 6 filter papers, a pre-cooled electrotransfer tank and electrotransfer solution. Wear gloves when cutting the filter paper and PVDF membrane. Soak the PVDF membrane in pure methanol, place the gel sheet in the electrotransfer tank, scrape off the concentrated gel, and transfer it directly to the filter paper after cutting according to the molecular weight; make a sandwich structure, insert the jacket into the electrotransfer tank, add 4°C pre-cooled transfer buffer, maintain the current at 200 mA, and the transfer time is determined according to the molecular weight; after the electrotransfer is completed, disconnect the power supply and soak the PVDF membrane in 5% milk for blocking.
[0173] (5) Enzyme immunolocalization and development: Incubate the primary antibody: dilute the primary antibody according to the instructions and incubate on a horizontal shaker at 4°C overnight; wash the membrane three times with TBST at room temperature on a horizontal shaker for 5 minutes each time; incubate the secondary antibody: dilute the secondary antibody according to the instructions and incubate on a horizontal shaker at room temperature for 1 hour; wash the membrane three times with TBST at room temperature on a horizontal shaker for 10 minutes each time; develop: prepare the luminescent solution according to the required volume and perform luminescent imaging under a developer. Use Tanon 5200Multi to capture images, use ImageJ open source software to quantify the bands, and normalize the protein expression level to GAPDH.
[0174] 3. Immunohistochemical Staining of Paraffin Sections
[0175] (1) Baking: Place the paraffin sections on an iron slide rack and bake in a 60°C oven for 4 h. Take them out and leave them at room temperature. (2) Dewaxing: Wax immersion dewaxing transparent agent I treatment for 10 min, ring immersion dewaxing transparent agent I treatment for 10 min, anhydrous ethanol I treatment for 5 min, anhydrous ethanol II treatment for 5 min, 95% ethanol treatment for 5 min, 85% ethanol treatment for 5 min, 75% ethanol treatment for 5 min. (3) Wash with PBST 3 times, 5 min each time. (4) Microwave antigen retrieval: Pour the prepared antigen retrieval solution into a high temperature resistant plastic slide box and place Place the slide in a microwave oven on medium-high heat until boiling, insert the slide into a slide box, and heat on medium-low heat for 20 minutes (if the liquid boils, stop immediately), remove the slide box and cool to room temperature; (5) Wash with PBST three times, 5 minutes each time, wipe off the moisture on the edges and back, and draw circles around the tissue with a tissue pen; (6) Block endogenous peroxidase: Put a small amount of water in a light-proof humid box, place the slide in the humid box, add the "endogenous peroxidase blocker (reagent 1)" in the immunohistochemistry kit, and incubate at room temperature in the dark for 10 minutes; (7) Wash with PBST three times, 5 minutes each time; (8) Seal Blocking: wipe off the moisture on the edge and back, add the "serum blocking solution (reagent 2)" in the immunohistochemistry kit, and incubate at room temperature for 20 minutes; (9) Prepare the primary antibody with 1% BSA solution according to the instructions, wipe off the moisture on the edge and back, add the primary antibody according to the size of the tissue, cover and incubate in a wet box, and refrigerator at 4°C overnight; (10) Rewarming: Take out the wet box from the refrigerator, open it to see if the primary antibody has dried, cover it and put it in a 37°C water bath for 40 minutes; (11) Wash 3 times with PBST, 5 minutes each time; (12) Add the secondary antibody and incubate at room temperature for 25 minutes; (13) PBST Wash with ST for 3 times, 5 min each time; (14) Add enzyme-labeled streptomycin (reagent 4) and incubate at room temperature for 10 min. Meanwhile, prepare DAB solution (A solution: B solution: C solution = 20:1:1) according to the required amount in the dark; (15) Wash with PBST for 3 times, 5 min each time; (16) DAB color development: Add an appropriate amount of DAB under a microscope, observe and time the slides. When brown appears, immediately put them in the dyeing jar and rinse gently. Place them on the slide rack in the same direction. Stain the slides with the same indicators according to the same DAB staining time. After all slides are stained, rinse the back with tap water for 7 minutes. min to terminate the staining; (17) Hematoxylin counterstaining: remove the slides and wipe them dry, add hematoxylin to counterstain for 30 s (the time is adjusted according to the depth of hematoxylin staining), then immediately put them into the staining jar and rinse gently. Place the slides on the slide rack in the same direction. After all slides are stained, rinse the back under tap water until the color of the specimen returns to blue; (18) Dehydration and transparency: 75% ethanol treatment for 5 min, 85% ethanol treatment for 5 min, 95% ethanol treatment for 5 min, anhydrous ethanol II treatment for 5 min, anhydrous ethanol I treatment for 5 min, wax dewaxing transparent agent II treatment for 10 min, wax dewaxing transparent agent I treatment for 10 min; (19) Neutral gum sealing;(20) Observe the histopathological changes under a microscope and take photos.
[0176] 4. Verification of FUNDC1 expression levels in human skin tissues from non-exposed and exposed areas
[0177] The collected human skin tissues were paraffin-embedded and sectioned as before, and the expression level of FUNDC1 was detected by immunohistochemistry. The basic information of the specimens is shown in Table 1.
[0178] Table 1 Demographic data
[0179]
[0180] Apoptosis is a major form of regulated cell death, including the extrinsic pathway (or death receptor pathway) and the intrinsic pathway (or mitochondrial pathway). Apoptosis caused by mitochondrial apoptosis is an important pathway of cell death. The process of mitochondrial apoptosis is as follows: stimulation factors such as DNA damage recruit and activate Bcl2-associated X apoptosis regulator (Bax) / Bcl-2 gene family pro-apoptotic proteins (Bcl2-antagonist / killer, Bak) and Bcl-2 homology 3-only (BH3-only), causing changes in mitochondrial outer membrane permeability (mitochondrial outer membrane permeabilization, MOMP). MOMP causes the release of cytochrome C (cyto c) from the mitochondrial intermembrane space. Cytochrome C forms an apoptotic complex with apoptotic protease activating factor 1 (APAF1). The apoptotic complex then binds to and activates caspase 9, which then cleaves and activates caspase 3, causing cell apoptosis. Mitochondria are important regulators of endogenous apoptotic signals, among which the effector pro-apoptotic members of the B-cell lymphoma 2 (Bcl2) family of proteins (mainly Bax and Bak) initiate the signal cascade, ultimately leading to cell death. Studies have shown that after UVB irradiation of skin keratinocytes or fibroblasts, the Bcl2 / Bax ratio decreases, cytochrome C release increases, causing downstream caspase activation and triggering mitochondrial apoptosis.
[0181] The following are the test results of this embodiment.
[0182] 1. Western blot detection of UVB-induced mitochondrial apoptosis activation in the back skin of mice
[0183] In Example 1, it has been demonstrated that the mitochondrial pathway plays an important role in regulating apoptosis. In this example, proteins were extracted from the back skin of mice 24 h and 72 h after UVB irradiation, and the molecular cells of the mitochondrial apoptosis-related pathway were detected by Western blot.
[0184] Cytochrome C (also expressed as cyto c), Bcl2, Bax and cleaved caspase 3. The results are as follows Fig.14 shown. Fig.14 A is the Western blot result. Fig.14 B is the statistical results of the expression levels of cytochrome C, Bcl2, Bax and cleaved caspase 3. The results are expressed as mean ± standard deviation, N = 5, and P < 0.05 indicates that the difference is statistically significant.
[0185] The expression level of cytochrome C was significantly upregulated after 72 hours of UVB irradiation; the expression level of Bcl2 was significantly downregulated after 72 hours of UVB irradiation; the expression level of Bax was significantly upregulated after 24 hours and 72 hours of UVB irradiation; the expression level of cleaved caspase3 was significantly upregulated after 72 hours of UVB irradiation. The above results show that UVB irradiation of the back skin of mice activates the mitochondrial apoptosis pathway.
[0186] 2. Immunohistochemical detection of UVB-induced mitochondrial apoptosis activation in the back skin of mice
[0187] Furthermore, this example used paraffin-embedded sections of the back skin of mice irradiated with UVB and immunohistochemical tests to detect changes in cytochrome C, Bcl2, Bax and cleaved caspase 3, and further verified the changes in mitochondrial apoptosis-related molecules after UVB irradiation of the back skin of mice. The results are as follows: Fig.15 In the figure, control refers to the blank control group without light exposure.
[0188] Fig.15 The results show the changes in the expression of mitochondrial apoptosis-related molecules after UVB irradiation of the mouse back skin. Fig.15 A is the staining result of immunohistochemistry for cytochrome C, Bcl2, Bax and cleaved-caspase 3. Fig.15B is the statistical result of Western blot detection of protein expression levels of cytochrome C, Bcl2, Bax and cleaved-caspase 3. The results are expressed as mean ± standard deviation, N = 5, p < 0.05 indicates that the difference is statistically significant. Scale bar 200 μm.
[0189] The trend was consistent with that of Western blot. Compared with the blank control group, after UVB irradiation, cytochrome C was significantly upregulated at 24h and 72h, Bcl2 was significantly downregulated at 24h and 72h, Bax was significantly upregulated at 24h and 72h, and cleaved caspase3 was significantly upregulated at 24h and 72h. The upregulation of cytochrome C and Bax and the downregulation of Bcl2 were time-dependent, and cleaved caspase3 reached a peak at 24h after irradiation. Combining the results of Western blot and immunohistochemistry, it can be proved that UVB irradiation of the back skin of mice induced the activation of the mitochondrial apoptosis pathway.
[0190] 3. UVB induces mitochondrial apoptosis activation in HaCaT cells
[0191] In this example, HaCaT cells were irradiated with UVB, proteins were extracted at different time points (1, 3, 6, 12, and 24 h), and the expression levels of cytochrome C, Bcl2, Bax, and cleaved-caspase 3 were detected to further verify that the mitochondrial apoptosis pathway was also activated in the light damage model established by UVB irradiation of HaCaT cells. The results are shown in FIG. Fig.16 shown. Fig.16 A: Western blot detection of protein expression levels of cytochrome C, Bcl2, Bax and cleaved-caspase 3. Fig.16 B is the statistical results of the expression levels of cytochrome C, Bcl2 / Bax and cleaved-caspase 3. The results are expressed as mean ± standard deviation, N = 3, and P < 0.05 indicates that the difference is statistically significant.
[0192] After UVB irradiation, cytochrome C began to upregulate at 6 h and reached a peak at 12 h ( Fig.16 A and Fig.16 B), the ratio of Bcl2 / Bax showed a significant downregulation at 3h ( Fig.16 B), cleaved caspase 3 was significantly upregulated and reached a peak at 6h. The results showed that after UVB irradiation of HaCaT cells, the mitochondrial apoptosis pathway was activated, which was consistent with the results of C57BL / 6 mice.
[0193] 4. Western blot detection of UVB-induced inhibition of mitochondrial autophagy in the back skin of mice
[0194] Autophagy is generally considered to be a global degradation process that non-selectively transports cytoplasmic components such as nucleic acids, proteins, and organelles to lysosomes. Mitophagy is one of the autophagic pathways that maintains the cellular structure and function of specific organelles. Mitophagy targets damaged mitochondria in cells and delivers them to lysosomes for degradation. This process helps to ensure the control of mitochondrial quality and quantity. The disruption of mitochondrial membrane potential is a powerful trigger for mitophagy. In mammals, mitophagy includes ubiquitin-mediated (PINK1 / Parkin) mitophagy and receptor-mediated (Bcl2-interacting protein 3, BNIP3; Nip3-likeproteinX / BNIP3-likeprotein, NIX / BNIP3L; FUN14 domain-containing protein 1, FUNDC1) mitophagy. PINK1 can phosphorylate ubiquitin, thereby recruiting and activating Parkin in the cytoplasm, which can catalyze ubiquitination to generate more ubiquitin chains.
[0195] Studies have shown that decreased levels of PINK1 and parkin indicate impaired mitochondrial autophagy. After UVB irradiation, BNIP3 plays a role in the degradation of dysfunctional mitochondria, and its mediated autophagy occurs through ROS-induced activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), playing an important role in the skin's resistance to UVB damage.
[0196] The results of Example 1 show that mitochondrial damage caused by UVB irradiation is related to mitophagy. In this example, proteins were extracted from the back skin of mice after UVB irradiation at 24h and 72h, and Western blot was used to detect the expression changes of receptor-dependent mitophagy pathway-related molecules and ubiquitin-dependent mitophagy-related molecules to explore the molecules involved in the regulation of mitophagy after UVB irradiation. The results are as follows: Fig.17 shown. Fig.17 A: Western blot detection of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. Fig.17 B is the statistical results of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. The results are expressed as mean ± standard deviation, N = 5, and P < 0.05 indicates that the difference is statistically significant.
[0197] Western blot results showed that PINK1 and Parkin involved in the ubiquitin-dependent mitophagy pathway did not change before and after light exposure. BNIP3 involved in the receptor-dependent mitophagy pathway also did not change significantly before and after light exposure, while FUNDC1 was significantly downregulated after 24h and 72h of irradiation. Therefore, it is speculated that FUNDC1-mediated mitophagy plays an important role in UVB-induced skin photodamage.
[0198] 5. Immunofluorescence detection of UVB-induced downregulation of FUNDC1 in mouse back skin
[0199] To further verify the role of FUNDC1-mediated mitophagy pathway in UVB-induced photodamage, in this example, skin before and 24h and 72h after photoirradiation was embedded in OCT and frozen sectioned, and immunofluorescence was used to detect the co-localization expression of FUNDC1 and mitochondrial protein COX4. The results are as follows: Fig.18 shown.
[0200] Fig.18 A is the fluorescence intensity of FUNDC1 detected by tissue immunofluorescence after UVB irradiation. Green fluorescence represents COX4, red fluorescence represents FUNDC1, and blue represents DAPI. Fig.18 B is the statistical result of the fluorescence intensity of FUNDC1 after UVB irradiation. The results are expressed as mean ± standard deviation, N = 5, P < 0.05 indicates that the difference is statistically significant, scale bar 20 μm.
[0201] Immunofluorescence colocalization confirmed the interaction between FUNDC1 and COX4, indicating that FUNDC1 and COX4 colocalized in mitochondria. After UVB irradiation for 24h and 72h, FUNDC1 in the mouse epidermis was significantly downregulated in a dose-dependent manner, and the fluorescence intensity of FUNDC1 and COX4 colocalization was significantly downregulated at 24h and 72h, respectively.
[0202] 6. Immunofluorescence detection of UVB-induced LC3B downregulation in mouse back skin
[0203] In this example, immunofluorescence was used to detect the expression level of LC3B to further verify that the decrease of FUNDC1 in the back skin of mice induced by UVB irradiation inhibited receptor-mediated mitochondrial autophagy. Fig.19 shown.
[0204] Fig.19 A is the fluorescence intensity of LC3B after UVB irradiation detected by tissue immunofluorescence. Green fluorescence represents COX4, red fluorescence represents LC3B, and blue represents DAPI. Fig.19B is the statistical result of the fluorescence intensity of LC3B after UVB irradiation. The results are expressed as mean ± standard deviation, N = 5, P < 0.05 indicates that the difference is statistically significant, scale bar 20 μm.
[0205] After 72 hours of UVB irradiation, LC3B was downregulated and its colocalization with COX4 was reduced, which was consistent with the above-mentioned results of FUNDC1 downregulation and reduced colocalization of FUNDC1 and COX4. Based on this, this example infers that UVB irradiation of the back skin of mice inhibits FUNDC1-mediated mitochondrial autophagy and causes skin photodamage.
[0206] 7. Western blot detection of inhibition of mitochondrial autophagy in HaCaT cells induced by different doses of UVB
[0207] In this example, HaCaT cells were exposed to different doses of UVB (10, 20, 30 mJ / cm 2 ) 24 hours after irradiation, the protein of the cells was extracted, and the molecules related to the receptor-dependent mitophagy pathway and the ubiquitin-dependent mitophagy pathway were detected by Western blot to verify again that UVB irradiation of the skin inhibited mitophagy. The results are as follows Fig. 20 shown.
[0208] Fig. 20 A: Western blot detection of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. Fig. 20 B is the statistical results of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. The results are expressed as mean ± standard deviation, N = 3, and P < 0.05 indicates that the difference is statistically significant.
[0209] FUNDC1 at UVB 10 and 20 mJ / cm 2 There was no significant change after irradiation at 30mJ / cm 2 BNIP3 was significantly downregulated after irradiation. 2 No significant changes after irradiation, 30mJ / cm 2 After irradiation, there was a significant upregulation. There was no difference in PINK1 and Parkin after different doses of UVB irradiation.
[0210] In the experiment of measuring the survival rate of HaCaT cells after irradiation with different doses of UVB in Example 1, the UVB dose was 30 mJ / cm 2When the cell viability began to decline significantly, it was about 60%, and obvious mitochondrial damage was shown. At the same time, the photodamage model of HaCaT cells was successfully established. Based on this, the UVB was selected to be 30mJ / cm 2 Conduct subsequent experiments.
[0211] 8. Western blot detection of UVB-induced inhibition of mitochondrial autophagy in HaCaT cells at different time points
[0212] In this example, HaCaT cells were exposed to UVB at 30 mJ / cm 2 After irradiation, the proteins of the cells were extracted at different time points (1, 3, 6, 12, and 24 h), and the molecules related to the receptor-dependent mitophagy pathway and the ubiquitin-dependent mitophagy pathway were detected by Western blot to further detect the changes in mitophagy-related molecules after UVB irradiation at different time points. The results are shown in Fig.21 shown.
[0213] Fig.21 A: Western blot detection of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. Fig.21 B is the statistical results of the protein expression levels of FUNDC1, BNIP3, PINK1, and Parkin. The results are expressed as mean ± standard deviation, N = 3, and P < 0.05 indicates that the difference is statistically significant.
[0214] FUNDC1 showed no significant changes at 1, 3, 6, and 12 hours after UVB irradiation of HaCaT cells, but was significantly downregulated at 24 hours. BNIP3 showed no significant changes at 1, 3, and 6 hours after UVB irradiation, but was significantly upregulated at 12 hours and 24 hours. However, PINK1 and Parkin showed no significant differences after UVB irradiation at different time points. Combined with the results of the above mouse experiments, PINK1 / Parkin showed no significant changes at different doses and time points of UVB; in cells, BNIP3 was significantly upregulated after UVB irradiation, but there was no significant difference in mice, and the upregulation of BNIP3 was inconsistent with the change trend of LC3B. FUNDC1 was significantly downregulated in both mice and cells after UVB irradiation, and the downregulation of FUNDC1 was consistent with the downregulation of LC3B.
[0215] Therefore, subsequent experiments further explored the role of FUNDC1-mediated mitophagy in UVB-induced skin photodamage.
[0216] 9. Immunofluorescence detection of FUNDC1 downregulation in HaCaT cells after UVB irradiation
[0217] In this example, FUNDC1 was further verified by cell immunofluorescence to confirm the downregulation of FUNDC1 after UVB irradiation of HaCaT cells. Fig. 22 shown.
[0218] Fig. 22 A is the fluorescence intensity of FUNDC1 detected by cell immunofluorescence after UVB irradiation. Green fluorescence represents COX4, red fluorescence represents FUNDC1, and blue represents DAPI. Fig. 22 B is the statistical result of the fluorescence intensity of FUNDC1 after UVB irradiation. The results are expressed as mean ± standard deviation, N = 3, P < 0.05 indicates that the difference is statistically significant, scale bar 20 μm.
[0219] In UVB: 30mJ / cm 2 FUNDC1 and COX4 immunofluorescence co-localization detection was performed 24 hours after irradiation of HaCaT cells. After UVB irradiation of HaCaT cells, FUNDC1 was significantly downregulated ( Fig. 22 B), and the colocalization with COX4 was also reduced ( Fig. 22 A).
[0220] 10. Immunofluorescence detection of UVB-induced decrease of LC3B in HaCaT cells
[0221] LC3B was further validated by cell immunofluorescence to confirm the inhibition of FUNDC1-mediated mitophagy after UVB irradiation of HaCaT cells. Fig.23 shown.
[0222] Fig.23 A is the fluorescence intensity of LC3B detected by cell immunofluorescence after UVB irradiation. Green fluorescence represents COX4, red fluorescence represents LC3B, and blue represents DAPI. Fig.23 B is the statistical result of fluorescence intensity of LC3B after UVB irradiation. The results are expressed as mean ± standard deviation, N = 3, P < 0.05 indicates that the difference is statistically significant, scale bar 20 μm.
[0223] After UVB irradiation of HaCaT, LC3B expression was significantly downregulated, and colocalization with COX4 was also reduced, which was consistent with the above-mentioned results of FUNDC1 downregulation and reduced colocalization of FUNDC1 and COX4. This example also verified in HaCaT cells that UVB irradiation inhibited skin photodamage caused by FUNDC1-mediated mitochondrial autophagy.
[0224] 11. Expression levels of FUNDC1 in human skin in non-exposed and exposed groups
[0225] In this example, the expression of FUNDC1 in human skin tissue was detected by immunohistochemistry to verify the expression level of FUNDC1 in skin photodamage. The results are as follows: Fig.24 shown.
[0226] Fig.24 A shows the immunohistochemical results of FUNDC1 in human skin of non-exposed and exposed groups. Fig.24 B is the statistical result of immunohistochemistry of FUNDC1. The results are expressed as mean ± standard deviation, N = 5, P < 0.05 indicates that the difference is statistically significant. Scale bar 200 μm.
[0227] FUNDC1 was significantly decreased in the exposed area, suggesting inhibition of FUNDC1-mediated mitophagy in photodamaged tissue of human skin, which is consistent with the results of photodamage induced by UVB irradiation in C57BL / 6 mice and HaCaT cells.
[0228] Example 3
[0229] The above results demonstrate that mitochondrial damage occurs in mouse skin and HaCaT cells after UVB irradiation, thereby inducing cell apoptosis and leading to photodamage. Specifically, the above experimental results detected the expression of mitochondrial autophagy-related molecules after UVB irradiation of the back skin of mice by Western blot, and found that FUNDC1 decreased 24h and 72h after UVB irradiation, while BNIP3, PINK1 and Parkin remained unchanged. This shows that FUNDC1 receptor-mediated mitophagy plays a key role in UVB-induced photodamage, while ubiquitin-mediated (PINK1 / Parkin) mitophagy is not directly activated after UVB irradiation. Similarly, after exposure to 30mJ / cm 2 In HaCaT cells exposed to UVB, FUNDC1 levels decreased, while BNIP3 expression increased, indicating that changes in receptor-mediated mitophagy occurred after UVB irradiation. In addition, the aforementioned experiments also verified the expression of FUNDC1 in human specimens and found that FUNDC1 expression was reduced in sun-exposed skin, showing consistent downregulation in both mice and cells.
[0230] In this example, an overexpression experiment of FUNDC1 was performed to analyze whether mitochondrial autophagy can be enhanced to remove damaged mitochondria and achieve the purpose of reversing light damage.
[0231] Use the following method for verification.
[0232] 1. Lentivirus infection and construction of stable cell lines: hu6-mcs-cmv-puromycin lentivirus encoding FUNDC1 short hairpin RNA (shRNA1: 5'-GATTAAGAAACGAGCGAACAA-3' (SEQ ID NO: 1), shRNA2: 5'-GAAAGTGATGACGACTCTTAT-3' (SEQ ID NO: 2) or shRNA3: 5'-GCAAACTAGTATCTGCTGTAA-3' (SEQ ID NO: 3) and Ubi-MCS-SV40-puromycin lentivirus encoding full-length FUNDC1 cDNA (Shanghai Gene Medical Technology Co., Ltd.) were constructed for FUNDC1 silencing and overexpression, respectively. The restriction sites at both ends of the inserted shRNA fragment were AgeⅠ and EcoRⅠ (such as Fig.25 The forward and reverse complementary sequences of shRNA were synthesized respectively, as shown in Table 2, wherein CCGG and TTTTTG are the parts connected to the vector. Lentivirus (2×10 8 T U -1 ) infected HaCaT in the presence of 200 ng ml -1 Stable clones were obtained by culturing in complete DMEM containing puromycin for 2 weeks. The infected cell samples were named F1 sh (FUNDC1 silencing group) or F1 OE (FUNDC1 overexpression group). The blank treatment was used as a control to verify the expression of FUNDC1 before further experiments.
[0233] Table 2
[0234]
[0235] 2. Quantitative RT-PCR: According to the instructions, the SteadyPure universal RNA extraction kit (Accurate Biology, China) was used to extract total intracellular RNA from HaCaT cells, and the RNA concentration was determined using an ultra-micro UV spectrophotometer. RNA was used in a cDNA synthesis kit (Accurate Biology, China) to synthesize the first-chain cDNA. SYBRGreen Real-time PCR Master Mix (Accurate Biology, China) was used to perform real-time fluorescence quantitative PCR analysis on Applied Biosystems QuantStudio 1 (Applied Biosystems, USA) through melting curves, and the gene expression was analyzed using the 2-ΔCT method. GAPDH mRNA was used as an internal reference to relatively quantify the level of the target mRNA. The present invention uses the following primers: gene GAPDH, F: 5'-TGTAGGCTCATTTGCAGGGG-3' (SEQ ID NO: 10); R: 5'-TCCCATTCCCCAGCTCTCAT-3' (SEQ ID NO: 11), gene size 317 bp. Gene FUNDC1, F: 5'-ACAGTTCGGGACCTATGGTAGA-3' (SEQ ID NO: 12); R: 5'-CAGAAATCCTGCACACCAGCC-3' (SEQ ID NO: 13), gene size 86 bp. F is the forward primer, i.e., the upstream primer; R is the reverse primer, i.e., the downstream primer.
[0236] 3. Western blot: the method is the same as above and will not be repeated here.
[0237] The following are the experimental results.
[0238] 1. FUNDC1 overexpression enhances UVB-induced photodamage
[0239] Under normal conditions, the survival rate of HaCaT cells after UVB irradiation is about 60%. Fig.26 (FUNDC1 overexpression enhances UVB-induced photodamage) showed that when FUNDC1 was overexpressed in HaCaT cells, the cell survival rate was significantly reduced to about 30%.
[0240] Fig.26 A is the expression level detection result of FUNDC1 overexpression. Fig.26B is the statistical results of CCK8 detection of cell viability, DCFH-DA detection of ROS level, and YP1 (also represented as YO-PRO-1 in the figure) and PI detection of cell apoptosis and necrosis. Green fluorescence represents YP1 and red represents PI. Scale bar 200μm. Fig.26 C is the result of cell immunofluorescence detection of γH2Ax expression. Fig.26 D is the statistical result of CCK8 detection of cell viability (cell activity). Fig.26 E is the statistical result of DCFH-DA detection of ROS levels. Fig.26 F is the statistical result of the fluorescence intensity of YP1. Fig.26 G is the statistical result of the fluorescence intensity of PI. Fig.26 F is the statistical result of the fluorescence intensity of γH2Ax. Blue represents DAPI and green represents γH2Ax. Scale bar 20 μm. p value < 0.05 indicates that the difference is statistically significant.
[0241] Fig.26 The results showed that after overexpression of FUNDC1 in HaCaT cells, the cell survival rate was significantly reduced; the ROS level in HaCaT cells was significantly increased in the F1 OE-UVB group; YP1 and PI in the F1 OE-UVB group increased after UVB irradiation, showing enhanced cell apoptosis and necrosis; γH2Ax expression was significantly increased in the F1 OE-UVB group, which was consistent with the initial belief that overexpression of FUNDC1 could enhance mitophagy and the clearance of damaged mitochondria to protect cells from UVB-induced photodamage.
[0242] Unexpectedly, overexpression of FUNDC1 actually exacerbated UVB-induced photodamage.
[0243] Furthermore, FUNDC1 overexpression was performed to evaluate mitochondrial morphology, mtROS, MMP, and ATP levels after UVB irradiation, and the results are shown in 27 .
[0244] Fig. 27 A is the detection result of the fluorescence intensity of MitoTracker Red CMXRos (also represented as MitoTracker in the figure). Fig. 27 B is the detection result of the fluorescence intensity of MitoSOX Red Mitochondrial Superoxide Indicator (also represented as mtROS in the figure). Fig. 27 C is the detection result of the fluorescence intensity of JC-1. For MitoTracker, red represents mitochondria and blue represents DAPI. For MitoSOX, red represents mtROS and blue represents DAPI. For JC-1, red represents JC-1 aggregates and green represents monomers. Scale bar 200 μm. Fig. 27D is the result of cellular immunofluorescence co-localization of LC3B and COX4. Scale bar: 20 μm. Fig. 27 E is the statistical result of the fluorescence intensity of MitoTracker Red CMXRos (also represented as MitoTracker in the figure). Fig. 27 F is the aggregation length of the long axis of the nucleus. Fig. 27 G is the statistical result of the fluorescence intensity of mtROS. Fig. 27 H is the statistical result of the fluorescence intensity of JC-1 monomers / aggregates. Fig. 27 I is the statistical result of the fluorescence intensity of LC3B and COX4 cellular immunofluorescence co-localization. Fig. 27 J is ATP level. p value < 0.05 indicates that the difference is statistically significant.
[0245] MitoTracker Red CMXRos-labeled mitochondria were more obviously aggregated along the long axis of the nucleus in the F1 OE-UVB group; the red fluorescence intensity was enhanced in the F1 OE-UVB group, indicating a more severe mitochondrial depolarization; MitoSOX Red mitochondrial superoxide indicator representing mtROS was more aggregated in the mitochondria in the F1 OE-UVB group; for JC-1 staining, the red fluorescence representing J-aggregates decreased more, the green fluorescence representing monomers increased more, and MMP decreased more significantly compared with the UVB group ( Fig. 27 C and Fig. 27 H). LC3B expression was reduced after UVB irradiation but was restored by overexpression of FUNDC1 ( Fig. 27 I); COX4 expression decreased after UVB irradiation. Surprisingly, COX4 was not expressed in the F1 OE-UVB group under FUNDC1 overexpression conditions after UVB irradiation ( Fig. 27 I), showing mitochondrial loss. ATP levels decreased after UVB irradiation, and the decrease was more pronounced in the F1 OE-UVB group, showing ATP depletion ( Fig. 27 J).
[0246] According to the above results, FUNDC1 overexpression leads to more obvious mitochondrial damage and photodamage after UVB irradiation through ATP depletion, so FUNDC1 silencing experiments were subsequently performed to analyze whether it can rescue mitochondrial damage and photodamage after UVB irradiation.
[0247] 2. FUNDC1 silencing reduces UVB-induced photodamage
[0248] GeneChip (Shanghai, China) constructed an adeno-associated virus vector expressing short guide RNA (sgRNA) targeting the FUNDC1 gene sequence. The sgRNA sequences specifically include (all in 5' to 3' direction): AAVDJ-Fundc1-RNAi (129269-1): GAAAGCGATGACGAATCATAC (SEQ ID NO: 14); AAVDJ-Fundc1-RNAi (129270-2): GAAGACACCACTGGTGGAATC (SEQ ID NO: 15); AAVDJ-Fundc1-RNAi (129271-11): GTAGCTACTCAGATTGTAATG (SEQ ID NO: 16), and negative control: (SEQ ID NO: 17). The sgRNA forward and reverse complementary sequences were synthesized separately, as shown in Table 3, wherein ACCGG and TTTTT are the parts connected to the vector. The aforementioned sgRNA was synthesized and cloned into the GV757 (U6-MCS) vector, and the recombinant vector was detected by DNA sequencing. The virus suspension was injected intradermally into the mouse skin using a 1 ml syringe and a 30-gauge needle; 5 to 7 injections were performed per mouse, each with approximately 20 μl (equivalent to approximately 10 11 The mice in each experimental group were sacrificed 21 days after injection to detect the infection efficiency, and the group with the best knockdown effect was selected by Western blot.
[0249] Table 3
[0250]
[0251] Fig.28 The results of CCK8 detection of cell viability, DCFH-DA detection of ROS levels, and YP1 and PI detection of cell apoptosis and necrosis. Fig.28 A shows the mRNA expression results of different groups with silencing FUNDC1, which is used to screen the treatment group with better knockdown results. Fig.28 Based on the results of A, the F1 Sh2 treatment group was selected for subsequent experiments. Fig.28 B shows the results of detecting cell viability with CCK8, detecting ROS levels with DCFH-DA, and detecting cell apoptosis and necrosis with YP1 and PI. Green fluorescence represents YP1, and red represents PI. Scale bar: 200 μm. Fig.28 C is the result of cell immunofluorescence detection of γH2Ax expression. Blue represents DAPI, and green represents γH2Ax. Scale bar 20μm. Fig.28 D is the statistical result of CCK8 detection of cell viability (cell activity). Fig.28 E is the statistical result of ROS level. Fig.28 F is the statistical result of YP1 fluorescence intensity. Fig.28 G is the statistical result of γH2Ax fluorescence intensity. Fig.28 H is the statistical result of PI fluorescence intensity. p value < 0.05 indicates that the difference is statistically significant.
[0252] In terms of cell survival rate, the cell survival rate in the F1 Sh2-UVB group increased to 80% compared to 60% in the UVB group ( Fig.28 D); As the green fluorescence decreased, the intracellular ROS level in the F1 Sh2-UVB group decreased ( Fig.28 E); The levels of apoptosis and necrosis indicated by YP1 and PI showed that both green fluorescence and red fluorescence decreased in the F1 Sh2-UVB group. Compared with the UVB group, the nuclear damage represented by γH2Ax expression in the F1 Sh2-UVB group was largely alleviated ( Fig.28 G). That is, FUNDC1 silencing cannot completely reverse UVB-induced photodamage, but can alleviate some of the photodamage.
[0253] We further evaluated the effects of FUNDC1 silencing on mitochondrial morphology, mtROS, MMP, and ATP levels after UVB irradiation. Fig.29 shown. Fig.29 A is the fluorescence intensity of MitoTracker Red CMXRos. Fig.29 B is the fluorescence intensity of MitoSOX Red Mitochondrial Superoxide Indicator (mtROS). Fig.29 C is the fluorescence intensity of JC-1. For MitoTracker, red represents mitochondria and blue represents DAPI; for MitoSOX, red represents mtROS and blue represents DAPI; for JC-1, red represents J-aggregates and green represents monomers. Scale bar 200 μm. Fig.29 D is the co-localization of LC3B and COX4 by immunofluorescence. Scale bar: 20 μm. Fig.29 E is the statistical result of the fluorescence intensity of MitoTracker Red CMXRos. Fig.29 F is the aggregation length of the long axis of the nucleus. Fig.29 G is the statistical result of the fluorescence intensity of mtROS. Fig.29 H is the statistical result of the fluorescence intensity of JC-1 monomers / aggregates. Fig.29 I is the statistical result of the fluorescence intensity of LC3B and COX4 cell immunofluorescence co-localization. P value < 0.05 indicates that the difference is statistically significant.
[0254] After UVB irradiation, mitochondrial damage was rescued under FUNDC1 silencing conditions. In the F1 Sh2-UVB group, mitochondria labeled with MitoTracker Red CMXRos restored uniform distribution ( Fig.29 A), compared with the blank control group, there was no significant change in the distribution of mitochondria in the UVB group; the recovery of red fluorescence intensity was consistent with that in the control group, showing the recovery of mitochondrial membrane potential (MMP) in the F1 Sh2-UVB group ( Fig.29 C); compared with the UVB group, mtROS in the F1 Sh2-UVB group was alleviated ( Fig.29 B and Fig.29 G); For JC-1 staining, red fluorescence increased and green fluorescence decreased, and compared with the UVB group, the F1 Sh2-UVB group showed partial mitochondrial repolarization ( Fig.29 C and Fig.29 H). Compared with the UVB group, the expression of LC3B in the F1 Sh2-UVB group did not change significantly ( Fig.29 D and Fig.29 I), indicating that FUNDC1 silencing had no effect on LC3B. Surprisingly, COX4 expression in the F1 Sh2-UVB group did not decrease but increased compared with the UVB group ( Fig.29 I).
[0255] In summary, FUNDC1 silencing alleviated UVB-induced mitochondrial damage and photodamage.
[0256] 3. FUNDC1 silencing protects mitochondria from apoptosis by complementing PINK1-Parkin-mediated mitophagy.
[0257] Previous studies have shown that, in the context of sublethal MOMP (mitochondrial outer membrane permeabilization), PINK1-Parkin-mediated mitophagy promotes the restoration of cellular homeostasis by catalyzing the ubiquitination-dependent inactivation of BAK1 / Bax.
[0258] Fig.30 A shows the protein expression levels of FUNDC1, BNIP3, PINK1, Parkin, Bcl2 and Bax. Fig.30 B is the statistical result of FUNDC1 protein expression level. Fig.30 C is the statistical result of BNIP3 protein expression level. Fig.30 D is the statistical result of PINK1 protein expression level. Fig.30 E is the statistical result of Parkin protein expression level. 30F is the statistical result of Bcl2 protein expression level. 30G is the statistical result of Bax protein expression level. P value < 0.05 indicates that the difference is statistically significant.
[0259] Fig.30 Western blot results showed that the anti-apoptotic protein Bcl2 was decreased in the UVB group, but upregulated in the F1 Sh2-UVB group ( Fig.30 A and Fig.30 F). Compared with the UVB group, the pro-apoptotic protein Bax decreased in the F1 Sh2-UVB group ( Fig.30 A and Fig.30 G). Downregulation of Bax and upregulation of Bcl2 alleviated mitochondrial apoptosis, thereby protecting against UVB-induced photodamage. After FUNDC1 silencing, the expression level of BNIP3 did not change significantly in the F1 Sh2-UVB group compared with the UVB group ( Fig.30 A and Fig.30 C), thus not providing receptor-mediated mitophagy. In addition, the expression of PINK1 was upregulated in the F1 Sh2-UVB group ( Fig.30 A and Fig.30 D), while the expression of Parkin did not change significantly ( Fig.30 A and Fig.30 E) PINK1 upregulation is associated with ubiquitin-mediated mitophagy, which is complementary to protective mitophagy and helps promote restoration of cellular homeostasis.
[0260] It should be noted that the above-mentioned specific embodiments are exemplary, and those skilled in the art can come up with various solutions inspired by the disclosure of the present invention, and these solutions also belong to the disclosure scope of the present invention and fall within the protection scope of the present invention. Those skilled in the art should understand that the present invention specification and its drawings are illustrative and do not constitute a limitation of the claims. The scope of protection of the present invention is defined by the claims and their equivalents. The present invention specification contains multiple inventive concepts, such as "according to a preferred embodiment" means that the corresponding paragraph discloses an independent concept, and the applicant reserves the right to file a divisional application based on each inventive concept. Throughout the text, the features guided by "according to a preferred embodiment" are only an optional method and should not be understood as a must-have setting. Therefore, the applicant reserves the right to abandon or delete the relevant preferred features at any time.
Claims
1. Use of a FUNDC1 inhibitor in the preparation of a drug for preventing and treating skin photodamage, characterized in that: The FUNDC1 inhibitors include small molecule compounds, high molecular weight polymers, polypeptides, proteins, nucleic acid substances or viruses that can regulate the expression of FUNDC1 in the subject, wherein the nucleic acid substances also include related substances related to FUNDC1 that are silenced, knocked out or partially knocked out by genetic engineering.
2. The use according to claim 1, characterized in that: The silencing in the genetic engineering method is to silence the FUNDC1 gene using shRNA.
3. The use according to claim 2, characterized in that: The sequence of the shRNA is shown in one of SEQ ID NO: 1 to SEQ ID NO:
3.
4. A shRNA sequence that specifically inhibits or reduces the expression of FUNDC1, characterized in that: Its sequence is shown in one of SEQ ID NO: 1 to SEQ ID NO:
3.
5. A carrier, characterized in that It comprises the shRNA sequence according to claim 4.
6. Use of the shRNA sequence according to claim 4 or the vector according to claim 5 in preparing a FUNDC1 gene-deficient cell line.
7. A kit for knocking down the FUNDC1 gene, characterized in that: It comprises the shRNA sequence according to claim 4 or the vector according to claim 5.
8. A sgRNA sequence that specifically inhibits or reduces the expression of FUNDC1, characterized in that: Its sequence is shown in one of SEQ ID NO: 14 to SEQ ID NO:
16.
9. A pharmaceutical composition for preventing and treating skin photodamage, characterized in that: It includes a FUNDC1 inhibitor and a pharmaceutically acceptable carrier or excipient, wherein the FUNDC1 inhibitor includes a small molecule compound, a high molecular polymer, a polypeptide, a protein, a nucleic acid substance or a virus that can regulate the expression of FUNDC1 in a subject, wherein the nucleic acid substance also includes a substance related to FUNDC1 that can be silenced, knocked out or partially knocked out by genetic engineering.
10. An application of FUNDC1 as a target in screening drugs for preventing and treating photodamage of the skin.
Citation Information
Patent Citations
Application of FUNDC1 in preparation of medicine for preventing and treating vascular and tumor diseases
CN113171459A
Application of FUNDC1 in medicine for preventing and treating vascular senescence
CN114159562A
Electric distributing box in an apartment house
KR102085291B1
